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This work encompasses the structure of four different proteins, all of which 
were solved by X-ray crystallography. The structure of thiazole synthase (Thi4) in 
Saccharomyces cerevisiae involves the catabolism of another cofactor, nicotinamide 
adenine dinucleotide (NAD), through a series of catalytic steps that are now 
understood in light of several structural and biochemical studies. The product of the 
Thi4 reaction is an adenylated thiazole carboxylate, which is an unprecedented 
molecule found in primary metabolism. Thi4 also has a flavin adenine dinucleotide 
(FAD) binding fold, yet does not bind FAD.  This implies that an ancient predecessor 
of Thi4 was able to bind FAD and evolved to bind NAD as a substrate without a 
change in topology.  
The biosynthesis of cysteine in Mycobacterium tuberculosis involves a sulfur 
transfer step that uses a thiocarboxylated protein as the sulfur source. The protein 
complex structure of the cysteine synthase CysM and sulfur carrier protein CysO gives 
insight into how this reaction occurs. CysO has a β-grasp fold and is structurally 
similar to ubiquitin. The enzyme CysM binds to CysO in a pyridoxal 5´-phosphate 
dependent reaction with O-acetylserine (OAS) as the substrate to generate a cysteine 
residue on the C-terminus of CysO. CysM binds CysO through a loop that is ordered 
when CysO is bound and disordered when CysO is absent. Although there are other 
examples of proteins that bind to a sulfur carrier protein with a β-grasp fold, they all 
 differ in their composition of surface electrostatics responsible for protein-protein 
interactions.  
The structure of the enzyme purine nucleoside phosphorylase (PNP) from the 
thermophile Thermotoga maritima is an example of a protein that has the same overall 
fold as its mesophilic counterpart bovine PNP, yet is stable at considerably higher 
temperatures. The differences in thermal stability are seen in the fewer number of 
glycine and greater number of proline residues in TmPNP over bPNP. Also, the 
protein-protein interactions between monomers in the biological unit of TmPNP 
contain a greater number of hydrophobic residues, thereby leading tighter packing and 
greater thermostability. 
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CHAPTER ONE 
INTRODUCTION 
Section 1.1 General Comments on Structural Biology 
Modern methods in structural biology have changed the field that was once a science 
only practiced by a handful of creative computer programmers, crystallographers and 
chemists. Research in structural biology using X-ray crystallography has been 
streamlined through investments in better beamlines and tools for doing day to day 
crystallography experiments (1). Crystal screening is done using kits instead of 
making solutions from scratch, and sophisticated robots are capable of assembling 
screens using minute amounts of protein. Third generation synchrotrons have made 
improvements in overall brilliance, allowing for shorter exposure times and higher 
quality data.  Advances in microdiffractometry allow for data collection on crystals 
that would have been too small to be useful a decade ago.   
A testament to the impact of structural biology can be seen in the Nobel Prize 
lectures given by many laureates that include protein structures. The 2007 Nobel Prize 
in Chemistry given to Roger Kornberg for his work on “The molecular basis of 
eukaryotic transcription” was awarded in part due to X-ray structures of RNA 
polymerase II in complex with other transcription factors (2). The 2003 Nobel Prize in 
Chemistry was awarded to both Roderick MacKinnon and Peter Agre for their X-ray 
crystal structures of potassium and water channels, respectively (3). In recent years, 
nearly every Nobel Prize awarded for work done in biochemistry, cellular and 
molecular biology has been supported, at least in part, by either X-ray or, to a lesser 
extent NMR, protein structures.  
These contributions to biology are due to the accessibility of X-ray 
crystallography as a research tool to anybody who chooses to use it. Beamtime at 
national synchrotron sources is plentiful, and the support staff at beamlines provide the 
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technical expertise required for everything from data collection to structural solution. 
There exists a vast array of computer programs that assist in data reduction (4), 
phasing of anomalous data (5-10), molecular replacement (11, 12), model building 
(13, 14) and refinement (12, 15) that are freely available for academic use. Phasing of 
anomalous data has become easier with the use of selenomethionine derivitized 
proteins synthesized by methionine auxotrophic overexpression strains of Escherichia 
coli instead of laborious heavy metal atom screening. In the event that 
selenomethionine derivitized protein crystals cannot be grown, phasing using the 
sulfur atoms of cysteine and methionine in native protein crystals has been achieved at 
a wavelength of 1.54 Å using synchrotron radiation (16-18) and the copper Kα 
emission band from a rotating anode generator (19). A newer technique involving the 
use of a chromium X-ray source with a Kα emission band at 2.29 Å has also been 
used to generate anomalous datasets to solve protein structures through sulfur atom 
phasing (20-22). 
However, the limitations of X-ray crystallography are the same today as they 
have always been. The key to good X-ray protein crystal diffraction is a high quality 
crystal. Poorly ordered crystals will not diffract to atomic resolution, and small 
crystals suffer radiation decay faster than large ones which can affect the ability to 
collect a complete dataset. There are many was to address these problems such as 
extensive crystallization screening, mutating putative surface residues to decrease 
entropic effects (23), truncating multidomain enzymes and chemical cross-linking.  
One of the most effective methods is to screen several different orthologs of a 
particular enzyme. Since the surface residues are the ones involved in crystal packing, 
and are the least conserved residues among orthologous proteins, screening orthologs 
can increase the chance of obtaining a high quality crystal.   
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The future of structural biology lies in solving structures of large protein and 
protein-nucleic acid complexes, as well as solving structures of other proteins that are 
recalcitrant to crystallization.  Recent work on the X-ray crystal structure of the actin 
initiator Arp2/3 complex consists of seven different proteins that are required for this 
biochemical process (24-26). Large protein complexes like the ribosome (27-30), non-
ribosomal peptide synthases, fatty acid synthases (31, 32) and polyketide synthases are 
examples of large proteins that are the underpinning of some of the most important 
molecular biology of the cell. Without atomic resolution structures, currently only 
attainable through X-ray crystallography, we will never have more than a glimpse into 
the underlying chemistry behind these molecular machines. 
Section 1.2 Thiazole Biosynthesis 
Though much progress has been made in discovering the biosynthesis, uptake, salvage 
and regulation of thiamin in prokaryotes, comparatively little is still known about how 
eukaryotes make thiamin (Figure 1.1A).  Like in bacteria, each moiety of thiamin 
pyrophosphate is generated through a separate pathway, coupled by a single enzyme 
and phosphorylated by a variety of kinases.  The thiazole ring is made by the enzyme 
Thi4 from glycine, cysteine and a five carbon sugar (33-35).  Thi5 generates the HMP 
moiety using pyridoxine and histidine (36), and is subsequently phosporylated and 
pyrophosphorylated by Thi20 (37).  The two rings are joined by Thi6 (38) which is 
also a thiamin phosphate pyrophosphorylase and a hydroxyethylthiazole kinase (39).   
The most recent discoveries in eukaryotic thiamin biosynthesis have been in 
the production of the thiazole ring.  The enzyme Thi4 in yeast – Thi1 in Arabidopsis 
thaliana – is a homooctomer 35 kDa (30 kDa for Thi1) in size (Figure 1.1B).  
Orthologs of Thi4 in Fusarium oxysporum, F. solani (Sti35) and Aspergillus oryzae 
(ThiA) are transcriptionally regulated by TPP binding to a THI-box riboswitch (40).  
Thi4 is a dual function enzyme involved with mitochondrial DNA repair (41) as well  
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Figure 1.1: A) Overall thiamin biosynthetic pathway for S. cerevisiae.  B) X-ray 
crystal structure of Thi4.  C) Overall reaction catalyzed by Thi4.  Atoms in the 
thiazole moiety that are similar to both molecules are labeled in red and numbered. 
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as thiazole biosynthesis.  The discovery of a metabolite bound to Thi4 overexpressed 
in E. coli cells revealed an adenylated thiazole carboxylate (ADT) molecule through  
MS and NMR experiments (42).  Crystal structures of Thi4 (43) and Thi1 (44) showed 
clear density for ADT, confirming the presence of this unprecedented metabolite.  The 
adenylated ligand suggested that the substrate for Thi4 was a dinucleotide, but ADT 
was bound so tightly that it could not be removed from the native protein without 
denaturation.  The structure of Thi4 was used to conduct structure activity relationship 
studies in order to generate a mutant that did not have endogenously bound ADT but 
still retained catalytic activity.  C204S and H200N mutants produced an enzyme 
without a bound ligand yet were still biochemically active.  Thi4 was incubated in the 
presence of NAD and FAD and was shown to produce four different compounds with 
NAD while no reactivity was observed with FAD.  These compounds were identified 
as ADT, ADP-ribose, ADP-ribulose and an advanced intermediate which resulted 
from incubation of  the C204A mutant of Thi4 with NAD and glycine (45).  This 
represented the first example in a biosynthetic pathway where a co-factor is degraded 
to contribute to the molecular structure of another cofactor (46) (Figure 1.1C). 
Section 1.3 Cysteine Biosynthesis 
The biosynthesis of cysteine for most bacteria is done using O-acetylserine and sulfide 
as substrates for the pyridoxal 5´-phosphate (PLP)-dependent enzyme cysteine 
synthase (CS)/O-acetylserine sulfhydrylase (OASS) (47). The reaction is carried out 
through an α-aminoacrylate intermediate that serves as the electrophile for sulfide 
(48). Under normal growth conditions sulfide is relatively stable. However, the life 
cycle of Mycobacterium tuberculosis is more complex, as these bacteria possess 
several mechanisms allowing for their reproduction within the vacuole of 
macrophages. Some of these strategies include the ability to prevent the fusion of a 
phagosome containing the internalized bacterium with the host cell’s lysosomal 
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system (49), the complex system of biologically active compounds which comprise 
the unique cell wall (50-54) and the expression of a catalase-peroxidase that protects 
the cell from oxidizing agents within the macrophage (55).  
Another strategy is for the organism to eliminate the need for sulfate altogether 
in cysteine biosynthesis. In a highly oxidative environment, sulfide will oxidize to 
form a much less reactive sulfate ion, which is not a substrate for CS/OASS enzymes. 
A series of genes in the M. tuberculosis genome have been shown to be upregulated 
when bacilli are exposed to oxidative stress similar to the vacuole of a macrophage 
(56). Genes annotated as a cysteine synthase (CysM – Rv1336) a sulfur carry protein 
(CysO – Rv1335) and a zinc-hydrolase with a JAMM; Jab1/MPN domain 
metalloenzyme motif (Mec+ – Rv1334) are responsible for this alternative pathway. 
CysO is posttranslationally modified to have a thiocarboxy C-terminus that serves as 
the sulfur source. This is done by another enzyme, MoeZ (Rv3206), which contains 
both adenyltransferase and rhodenase domains (57). CysO has a ubiquitin like fold, 
and is structurally similar to previously characterized sulfur carry proteins ThiS (58) 
and MoaD (59). CysM forms an α-aminoacrylate intermediate using O-acetylserine as 
the substrate like in other OASS enzymes (57). CysO binds to CysM with its 
thiocarboxy C-terminal tail pointing into the active site to deliver the sulfur atom. A 
CysO-cysteine adduct forms with a conventional peptide bond that is then cleaved 
through the hydrolytic activity of Mec+ to release free cysteine.  
Section 1.4 Purine Salvage 
Purine nucleoside phosphorylase (PNP) enzymes are involved in the purine salvage 
pathway through reversible catalysis of purine nucleosides to generate a purine base 
and ribose 1-phosphate (60). This salvage pathway allows for the cell to metabolize 
preformed nucleotides into precursors for the synthesis of other nucleotides, thus 
bypassing the need for de novo nucleotide biosynthesis. 
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 The fold and biological unit of bovine PNP (bPNP) (61) and Thermotoga 
maritima PNP (TmPNP) are the same, but each enzyme must function in a very 
different environment. The mesophilic enzyme bPNP is catalytically active and stable 
at a typical bovine calf internal temperature of 38.6°C, while TmPNP is active and 
stable at temperatures of up to 90°C (62).  Some of the key structural differences 
between thermophiles and mesophiles are the number of proline residues, the presence 
of intramolecular disulfide bridges, number of salt bridges, hydrogen bonds, accessible 
surface area, increased polar surface area, hydrophibicity, fewer loop regions and 
greater compactness (63, 64).  Many of these factors are interrelated, and it should be 
clear that strong intramolecular and intermolecular interactions, regardless of type, 
will ultimately lead to an increase in ΔG of protein unfolding. Comparison between 
TmPNP and bPNP show that these factors are present, and are largely the cause of 
their relative stabilities at high temperatures.  
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CHAPTER TWO 
 
STRUCTURAL INSIGHTS INTO THE FUNCTION OF THE THAMIN 
BIOSYNTHETIC ENZYME THI4 FROM SACCHAROMYCES CEREVISIAE* 
 
Section 2.1 Introduction 
Thiamin pyrophosphate 6 plays a key role in amino acid and carbohydrate metabolism 
and is an essential cofactor in all living systems. Its biosynthesis requires the separate 
formation of the pyrimidine 5 and thiazole 4 heterocycles, which are then coupled to 
form the cofactor (Scheme 1). The mechanism of the thiazole formation in bacteria 
has been elucidated and involves a complex oxidative condensation where five  
 
 
 
Scheme 2.1  
 
* Reproduced with permission from Jurgenson C. T., Chatterjee A., Begley T. P. and 
Ealick S. E. (2006) Biochemistry 45(37), 110601-11070. Copyright 2006 American 
Chemical Society  
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different enzymes catalyze reactions involving three different substrates (1-deoxy-D-
xylulose-5-phosphate 3, cysteine 2 and glycine 1 or tyrosine) (1). The bacterial 
biosynthesis of the pyrimidine moiety is still poorly understood. 
In contrast to the bacterial system, thiamin biosynthetic studies in eukaryotes 
are still at an early stage. Labeling studies in Saccharomyces cerevisiae have 
demonstrated that the thiamin thiazole is biosynthesized from an unidentified five 
carbon carbohydrate 7, glycine 1 and cysteine 2 (2-4) (Scheme 1). Only one  
eukaryotic thiazole biosynthetic enzyme has been identified (Thi4) (5). This enzyme is 
a 326 amino acid (35 kDa) cytosolic protein. Sequence analysis suggests a conserved 
dinucleotide binding motif but does not reveal a biochemical function. 
Our recently published results suggest an enzymatic mechanism whereby the 
cofactor nicotinamide adenine dinucleotide (NAD) is converted into adenosine 
diphospho-5-(β-ethyl)-4-methyl-thiazole-2-carboxylic acid (ADT) (6). The ADT  
ligand is tightly bound and can only be released in vitro upon protein denaturation.  In  
Scheme 2.2 
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this mechanism (Scheme 2), cleavage of the N-glycosyl bond of NAD 8 would give  
ADP ribose 9.  Ring opening of this hemi-acetal followed by tautomerization would 
give 10.  A second tautomerization followed by loss of water would give 12. 
Tautomerization of 12 to the diketone 13 followed by imine formation with glycine 1 
would give 14. Imine tautomerization to 15 sets up the system to react with the sulfur 
donor, depicted here as sulfide to give 16. Cyclization gives 17. Two dehydration 
reactions followed by a final tautomerization complete the thiazole formation in ADT 
20. This proposal suggests that the first step in thiazole formation is similar to the 
chemistry used in ADP ribosylation. 
Here, we report the structure of the S. cerevisiae thiazole synthase which 
reveals the nature of binding to ADT found in the enzyme active site. The 
identification of this product suggests that NAD is the source of the carbohydrate 
precursor and provides the first insight into the mechanism of thiamin thiazole 
biosynthesis in eukaryotes.   
Section 2.2 Materials and Methods 
Protein Production   
The overexpression vector for the THI4 gene was constructed at the Cornell Protein 
Facility by standard methods from genomic DNA harvested from cells obtained from 
the American Type Culture Collection.  THI4 was cloned into a pET28 overexpression 
vector encoding a 6x polyhistidine tag with a thrombin cleavage site located between 
the tag and the protein.  The vectors were transformed into B834(DE3) (Novagen) 
methionine auxotrophic Escherichia coli cells (Novagen).  Cells were grown in LB 
media at 37 °C until an OD600 of 1.0 was reached.  The cells were induced using 1 mM 
isopropyl-β-D-thiogalactopyranoside and were incubated for 16-18 hours at 18 °C.  
Cell pellets that were collected after induction were placed into a beaker containing 50 
mL of buffer with 5 mM imidazole, 0.5 M NaCl and 20 mM Tris at pH 7.9 (lysis 
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buffer) and lysed using sonication.  The cell lysate was separated from the insoluble 
cell particles by centrifugation at 58,000 g at 4 °C for 20 min. The supernatant was 
decanted and loaded onto a Ni-NTA affinity column equilibrated with the same buffer 
used in the lysis step.  The column with bound Thi4 was washed with lysis buffer 
containing 60 mM imidazole to remove any remaining proteins that may have affinity 
to the Ni column.  The protein was eluted by washing the column with lysis buffer 
containing 0.5 M imidazole.  The eluate was buffer exchanged into 20 mM Tris at pH 
7.9 using Bio-Rad DG size exclusion chromatography columns with a molecular 
weight cut off of 6 kDa as per the manufacturer’s instructions.  The resulting solution 
was then concentrated in an Amicon Ultra centrifugal filter with a molecular weight 
cut off of 10 kDa by spinning at 5,000 g for 30-45 min at 4 °C until the concentration 
reached 10-20 mg/mL as measured using the Bradford Assay.  The polyhistidine tag 
was removed using biotinylated thrombin from the Novagen Thrombin Cleavage 
Capture kit as per the manufacturer’s instructions.  Biotinylated thrombin was 
removed by adding streptavidin agarose beads to the reaction mixture, allowing it to 
equilibrate for 30 min, then collecting the beads through a spin filter.  The cleaved 
histidine tags were separated by running the filtrate through a Ni-NTA column 
equilibrated with 60 mM imidazole, 0.5 M NaCl and 20 mM Tris at pH 7.9.  The 
eluate was then buffer exchanged into 20 mM Tris at pH 7.9 and concentrated to 10-
20 mg/mL as described in the buffer exchange step with histidine tagged Thi4.  The 
final Thi4 protein product had the endogenously bound ligand ADT, which became 
apparent during structure determination and refinement. 
Crystallization and X-ray Data Collection   
The hanging drop vapor diffusion method was used to grow crystals of Thi4.  
The well solutions consisted of 1.65-2.00 M Li2SO4 and 0.1 M HEPES at pH 7.5.  A 
hanging drop containing 1 µL of 10 mg/mL of the polyhistidine tag cleaved Thi4 and 
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2 µL of well solution were mixed and incubated at 22 °C.  Cubic crystals appeared in 
two to four weeks and grew 100-200 µm along each edge.  Crystals were mounted 
onto a cryoloop and cryprotected by dipping into a saturated solution of Li2SO4 as 
prescribed by Rubinson et al. (7) before being plunged into liquid N2.  Data were 
collected on the A1 beamline at the Cornell High Energy Synchrotron Source using a 
Quantum 210 CCD detector (Area Detector Systems Corporation).   Individual frames 
were collected in 0.5 degree oscillations for 220 frames with an exposure time of 60 s 
per frame under a cryostream of liquid N2 with the crystal mounted 190 mm from the 
detector.  Integration and scaling of the data were done using the HKL2000 suite of 
programs (8).  Data collection statistics are shown in Table 2.1. 
Table 2.1. Data collection Statistics 
Resolution (Å) 1.82 
Space group I4 
Unit-cell parameters (Å)  
a 140.70 
c 73.33 
No. of reflections 280639 
No. of unique reflections 63286 
Redundancy 4.4 (3.1) 
Completeness 98.5 (94.0) 
Rsym a (%) 25.6 (4.5) 
I/σ(I) 22.7 (3.3) 
Numbers in parentheses are from the highest resolution shell. 
a Rsym = ΣΣi  | Ii - <I> | / Σ<I>, where <I> is the mean intensity of the 
N reflections with intensities Ii and common indices hkl. 
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Structure Determination 
The structure of Thi4 was determined using the method of molecular 
replacement with the structure of Thi1 from Arabidopsis thaliana (PDB code 1RP0) as 
the molecular replacement search model.  Refinement was carried out using rigid-
body refinement followed by simulated annealing using CNS (9)  as well as REFMAC  
Table 2.2. Refinement Statistics 
Resolution (Å) 1.82 
No. of non-H atoms 5192 
No. of protein atoms 4516 
No. of water atoms 598 
No. of ligand atoms 76 
R factor (%) a 19.6 
Rfree (%) b 23.1 
Ramachandran plot  
Most favored region (%) 90.7 
Additionally allowed regions (%) 7.4 
Generously allowed region (%) 1.0 
Disallowed region (%) 1.0 
r.m.s.deviations from ideal  
Bonds (Å) 0.027 
Angles (°) 2.2 
 a R factor = Σ | |Fobs| - K|Fcalc| | / Σhkl |Fobs|, where Fobs and Fcalc are the observed and 
calculated structure factors, respectively 
b Rfree was calculated using 5% of all reflections that were excluded at all stages of 
refinement. 
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from CCP4 (10) and model rebuilding using the graphics programs O (11) and COOT 
(12). The final refinement statistics are shown in Table 2.2.  All graphics were 
prepared using PyMOL (13) and ChemDraw (CambridgeSoft). 
Section 2.3 Results 
Monomer Structure  
Thi4 is a homooctamer with two monomers, designated A and B, per asymmetric unit.  
The N-terminal regions of chains A and B are disordered from residue 1 to 16 and 1 to 
15, respectively.  Other areas that have disordered loops for chain A include residues 
180-184, 200-202 and 239-240 and for chain B include residues 179-183, 199-202 and 
238-241.  The Thi4 monomer consists of ten β-strands and nine α-helices.  The 
labeled monomer and a topology diagram representation are shown in Figure 2.1.  The  
monomer consists of a central five-stranded parallel β-sheet flanked on one side by 
three α-helices, and on the other by an anti-parallel three-stranded β-sheet that lies 
between 8-9 Å above the plane of the central β-sheet, and is rotated by an angle of 
approximately 30 degrees.  Long α-helices are found on both the N-terminal and C-
terminal ends of the monomer.  The N-terminal amphipathic helix spans residues 45-
62.  The C-terminal helix spans residues 307-324 and is also amphipathic.  It is 
located in a cleft of the protein in close proximity to helices α7 and α2 and is involved 
in numerous interactions with the N-terminal region of the adjacent monomer.  The N-
terminal region is largely disordered with the first 16 residues of chain A and 15 
residues of chain B missing from the electron density.  The monomer chain contains 
two 310-helices with the first α-helix beginning at residue 45.  Thirty-one of the first 
44 residues are either hydrophilic or alanine, with the few large hydrophobic residues, 
such as Phe38 and Phe40, pointing toward the hydrophobic core of the protein. The 
largely hydrophilic nature of the N-terminus may be due to its location on the surface 
of the octomeric structure, thus lending to the solubility of the protein. 
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Figure 2.1. Structure of the Thi4 monomer.  A) Ribbon diagram showing ten β-
strands (magenta) and nine α-helices (blue).  The core of the monomer consists of a 
parallel β-sheet made of strands 1, 2, 5, 9 and 10 which are sandwiched between an 
antiparallel β-sheet below made of strands 6, 7 and 8, and an α-helical bundle made of 
helices 2, 3, 4, 8, 7 and 9 from above.  ADT is represented in stick form in the active 
site.  B)  Topology diagram of Thi4 highlighting the core five stranded β-sheet. 
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Pro121 is found in the cis conformation and follows a loop consisting of residues 98-
115.  Within this region is a triglycyl group which gives increased flexibility to the 
loop.  Isomerization of this proline could result in the breakage of some of the 
hydrogen bond contacts which hold ADT in place such as those contributed by Ser98 
and Gly105, thereby reducing the binding energy of ADT and allowing for its release 
and further catalysis. 
Octomer Structure 
 Thi4 exists as a homooctomer with the disordered and largely hydrophilic N-
terminal regions located on the exterior of the molecule (Figure 2.2).  The octomer has  
the shape of a ring with flattened sides with the inner and outer diameters measuring 
approximately 30 Å and 96 Å, respectively, and a thickness of approximately 60-70 Å. 
The active site of Thi4 is found in the 30 Å diameter inner ring, which allows 
sufficient room for the entry of substrate molecules.  The outer and inner surfaces are 
lined with hydrophilic residues with the overall magnitude of the electrostatic potential 
being positive both inside and outside the ring.  The octomeric complex may be 
viewed as a tetramer of dimers with many interdimeric contacts at the interface 
between two monomers.  The other major interface forms between adjacent dimers.  A 
stereoview of the dimeric complex is shown in Figure 2.3.  Two long α-helices, one 
from each chain, are seen flanking either side of a twofold axis, and are arranged in 
antiparallel fashion.  These helices correspond to α4 (Figures 2.1B and 2.3) and 
facilitate the formation of the dimer largely through hydrophobic and van der Waals 
interactions, with the exception of residues Thr151 and Ser154 which form short 
hydrogen bonds to Ser154 (2.71 Å) and Thr151 (2.76 Å) of the adjacent monomer, 
respectively.  The α1 helix passes orthogonally to the twofold axis at residue 58, and  
 25 
 
 
 
 
 
 
Figure 2.2. Structure of the Thi4 octomer.  A) Ribbon diagram viewed through the 
central cavity. B) Ribbon diagram rotated 90° about the horizontal axis relative to 
panel (A). Each monomer is labeled in a different color. 
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Figure 2.3. Stereoview of the tightly packed dimer.  Helices and strands are colored in 
blue and magenta, respectively, in chain A; helices and strands are labeled in red and 
yellow, respectively, in chain B.  The bound ligand is represented in stick form and 
can be seen in the active site of each monomer.  The first and last secondary structural 
elements (α1 and α9) are labeled for each monomer.  Helices α4 in each monomer are 
labeled to illustrate the main interaction in the dimer.  
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Table 2.3. Monomeric Interactions 
A chain B chain Interaction 
Tyr56, Phe57 Phe113 π-stacking 
Ala41 Arg119 N-NH1 hydrogen bond 
His24, Trp35 His315 π-stacking 
Glu33 Lys322 Oε-Nζ hydrogen bond 
His24 Glu318 Oε-Nζ hydrogen bond 
Thr23 Asn87 N-Oδ hydrogen bond 
interacts with the two short antiparallel β-strands β3 and β4 from chain B.  The loop 
regions between β2 and β3 and α8 and α9 from chain B are also in close proximity to 
the N-terminal region.  Table 2.3 lists hydrogen bonds and π-stacking interactions 
seen between chains A and B.  The interface between individual dimers occurs mostly 
along the edge containing the α1 helix.  The helix from one dimer (α1A) interacts 
with the α1 helix from the adjacent dimer (α1B) through three hydrogen bonding 
interactions between Arg50 and Asp61 of adjacent monomers.  Additionally, the α1A 
Table 2.4. Dimeric Interactions 
A dimer B dimer Interaction 
Arg44 Glu212 Oε-Nε hydrogen bond 
Glu45 Arg176 Oε-NH2 hydrogen bond 
Glu45 Met266 Oε-NH hydrogen bond 
Ser46 Glu212 Oδ-Oε hydrogen bond 
Ser46 Arg50 O-N hydrogen bond 
Ser49 Asn209 Oγ-Oδ hydrogen bond 
Arg50 Asp61 Nε-Oδ hydrogen bond 
Arg50 Asp61 Nε-O hydrogen bond 
Arg50 Asp61 NH2-O hydrogen bond 
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hydrogen bonds to β8, α7, and the loop region between β6 and β7 in the second 
dimer.  A summary of these hydrogen bonding interactions is shown in Table 2.4.  
Most other interactions between dimers are the result of hydrophobic interactions.   
Active site  
The small molecule adenosine diphospho 5-(β-ethyl)-4-methyl-thiazole-2-
carboxylic acid (ADT) (6) was bound to the Thi4 active site, which is located near the 
inner ring of the octomeric complex (Figure 2.4A).  The adenosine moiety runs along  
the first β-strand in the fold characteristic of a dinucleotide binding site. The purine 
base is stabilized through π-stacking interactions between Phe241 and Phe244.  
Hydrogen bonding requirements for the N1 and N6 atoms of adenine are satisfied 
through the amide nitrogen atom and carbonyl oxygen atom of Val170, respectively.  
The N3 atom forms a hydrogen bond with the amide nitrogen atom of Ser98 at a 
distance of 3.22 Å.  The 2′- and 3′-hydroxyl groups on the ribose ring are hydrogen 
bonded to Glu97, with the 2′-oxygen atom at a distance of 2.54 Å and 3′-oxygen atom 
at a distance of 2.82 Å from the nearest oxygen atom of the Glu97 side chain.  The 2′-
hydroxyl group also forms a hydrogen bond with Ser98 and a water molecule at a 
distance of 2.93 Å.  The 3′-hydroxyl group forms additional hydrogen bonds with the 
amide nitrogen atom of Gly104 and another water molecule.  
There are two hydrogen bonds to the O1 oxygen atom of the α-phosphate.  
One bond is to the amide nitrogen atom of Gly105, which is one of the three glycine 
residues seen in the triglycyl segment of the loop region connecting strands β2 and β3, 
and the other to a water molecule.  Two hydrogen bonds with the α-phosphate O2 
atom are formed through water molecules, but no bonds are made to side chains or the 
main chain.  O1 from the β-phosphate forms three hydrogen bonds: one to a water 
molecule, and one each to the hydroxyl group and an amide nitrogen atom of Ser76.  
Two hydrogen bonds are formed by O2: one to a water molecule and the other to the  
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Figure 2.4 The Thi4 active site.  A) Stereoview of the Thi4 ADT binding site.  All 
amino acid side chains responsible for binding of ADT are shown.  All residues are 
from a single chain, with the exception of Asp207′, which comes from another Thi4 
monomer.  Hydrogen bonds made between the residues and the ligand are represented 
as grey dashed lines. B) View of the thiazole moiety of ADT and the methionine triad 
which lies on one face of the heterocyclic ring. 
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amide nitrogen atom of Met291.  The O3 atom which bridges the pyrophosphate 
group to the thiazole moiety is near the sulfur atom of Met309.  This methionine 
together with Met291 and Met302 form an interesting three-fold symmetric triad just 
above the thiazole ring Figure 2.4B).   
The thiazole moiety forms several hydrogen bonds with the protein, most of 
which are using the carboxylate group (Figure 2.4A).  A single hydrogen bond exists 
between the nitrogen atom of the ring and a carbonyl group of Gly303.  The 
carboxylate group forms two hydrogen bonds to the guanidinium moiety of Arg301, 
with each oxygen atom binding to a different nitrogen atom.  The O1 atom from the 
carboxylate group also hydrogen bonds to the amide nitrogen atom of Gly303, while 
the O2 atom of the carboxylate group binds to Nε of His237.  The thiazole ring is held 
in place through interactions with Asp207 from an adjacent dimer, which is positioned 
just above the ring facing the inner surface of the octomeric ring.  One oxygen atom 
from Asp207 lies directly above the thiazole nitrogen at a distance of 3.29 Å while the 
other oxygen atom lies above the thiazole sulfur at a distance of 3.62 Å. The 
carboxylic acid of Asp207 forms a hydrogen bond with the carbonyl oxygen atom of 
Gly303 from another monomer in the octomeric complex.  The other face of the 
thiazole ring is held in place by the methionine triad: Met291, Met302 and Met309 
(Figure 2.4B). 
The electron density maps for ADT show clear density for the ADP moiety, 
but are less clear in the region of the thiazole ring (Figure 2.5). The largest peak height 
corresponds to the sulfur atom as expected but the density is weaker than expected in 
the region of the N-C2 bond.  The non-ideality of the final electron density map 
probably arises from the presence of ADT as well as minor contamination from one or 
two protein bound adenylated metabolites (6).  
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Section 2.4 Discussion 
Comparison of Thi4 and the A. thaliana Thi1  
The molecular search model used to determine the structure of the S. cerevisiae Thi4 
was the ortholog of Thi4 in A. thaliana (PDB code 1RP0) Thi1 (14).  The sequence 
identity between Thi1 and Thi4 is 67% with only 24 of 289 Thi1 residues in gap 
regions.  Though the topology of Thi4 and Thi1 are the same, Thi4 has 326 residues 
per chain, while Thi1 has only 284.  Two structural features account for most of this 
42 amino acid difference.  First, Thi4 contains an N-terminal extension of 32 residues 
compared to Thi1 and second, Thi4 contains a 15 amino acid insertion relative to Thi1 
between β8 and β9.  The middle of the loop contains a mostly hydrophilic segment 
(KNETRMK), faces a solvent channel in the crystal structure and is located away 
from the active site.  The loop is absent in most Thi4 orthologs and probably does not 
directly affect the catalytic function. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. Electron density for ADT.  The 2Fo-Fc map is contoured at 1.0 σ.  The 
figure was reproduced from Chatterjee, et al. (6). 
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Comparison of the Thi4 and Thi1 active sites reveals a tightly conserved 
arrangement around the thiazole moiety, despite a rotation of the thiazole ring of 
approximately 170° about the C5-C6 bond between the two structures.  Figure 2.6  
shows a superposition of ADT in both Thi1 and Thi4, highlighting residues that 
interact with the thiazole moiety.  Neither of the sulfur atoms in either structure form 
hydrogen bonds or close contacts with the surrounding residues, but the hydrogen 
bond between the thiazole nitrogen atom and Gly303 in the Thi4 structure is absent in 
Thi1.  Because the thiazole ring in Thi1 is rotated, the nitrogen atom in the thiazole of 
Thi1 binds to His189, Asp190, and a Zn2+ ion.  Asp238, which corresponds to Asp190 
in Thi1, has poor sidechain density in the A chain, and therefore has been modeled as 
alanine.  Also, there is no density at all for Asp238 in the B chain of Thi4, so a 
comparison of binding between proteins for this residue is not possible.  However, the  
 
 
Figure 2.6. Overlay of Thi1 (green) and Thi4 (blue) active site residues in contact 
with the thiazole moiety.  Asp207′/Asp174′ contributes from an adjacent Thi4/Thi1 
monomer.  The Zn2+ in Thi1 is shown as a blue sphere. 
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electron density peak for the ADT sulfur atom in the Thi4 complex is very high, so the  
conformation about the C5-C6 bond is well defined.  The electron density for Thi1 
shows no density for the C5 atom, which may indicate that different metabolites are 
present in the two structures. 
Conserved residues  
A sequence alignment carried out with 14 different orthologs of Thi4 using 
ClustalW (15) along with secondary structural features is shown in Figure 2.7.  Of 
those conserved residues, most are involved in interactions either within the protein or 
with its bound ligand.  A conserved region in Thi4 corresponding to residues 68-78 
aligns well with a dinucleotide binding motif (16).  The characteristic motif of 
φφGXGXXG, where φ is any hydrophobic residue and X is any residue, is retained 
among all the orthologs, with the exception of Methanococcoides burtonii which 
replaces the third glycine with an asparagine.  Many entirely conserved residues are 
involved in ligand binding including Glu97, Gly105, Asp207, His237 and Arg301 in 
Thi4.  Arg301 forms a hydrogen bond to both oxygen atoms on the carboxylate group 
attached to C2 of the thiazole ring.  Gly105 is part of a triglycyl region within a 
flexible loop, with the amide nitrogen of Gly105 satisfying a hydrogen bond with an 
oxygen atom on the α-phosphate of ADT.  Asp207 is found positioned above the 
thiazole ring with one oxygen atom at a distance of 3.29 Å while the other oxygen 
atom lies above the thiazole sulfur atom at a distance of 3.62 Å.  The carboxylate of 
Asp207 is positioned by a water molecule, which bridges the carboxylate moiety and 
the carbonyl oxygen atom of Gly105 from an adjacent dimer of the octomeric 
complex.  Gly303 is entirely conserved and hydrogen bonds with the thiazole ring 
through its backbone nitrogen atom.  The structure reveals that Asp207 hydrogen 
bonds to Gly303 and positions its backbone nitrogen atom to hydrogen bond to the 
carboxylate group from the thiazole ring.  His237 forms a hydrogen bond with the 
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carboxylate group of the thiazole moiety of ADT via the Nε atom, and may be 
involved in catalysis by acting as an active site base through activation by a water 
molecule which is hydrogen bonded to the Nδ nitrogen atom of the imidazole ring (see 
below).  Glu270 forms hydrogen bonds with the hydroxyl group of Thr305 and the 
amide nitrogen of Ala308.  Both of these residues are positioned after the loop 
containing Arg301, which is key in positioning the carboxylate group in ADT.  
Glu270 forms two hydrogen bonds to the guanidinium moiety of Arg119 which is the 
last residue in the last secondary structural element β3 that precedes the cis-proline 
Pro121. 
Other exclusively conserved residues within the structure do not directly bind 
to the ADT molecule.  Glu45 forms a salt bridge with Arg176 and makes a key dimer-
dimer interaction to stabilize the octomeric complex.  Though the arginine residue is 
not entirely conserved, it is usually replaced by lysine.  Asp67 forms a hydrogen bond 
with the amide nitrogen of Lys92 and binds three water molecules which are on the 
outer surface of the octomer.  This interaction serves to orient β2, which contains the 
Glu97 residue essential for positioning of the ribose ring of ADT.  Gly109 forms a 
hydrogen bond with Phe113, but is also part of the flexible loop region, which also 
contains the triglycyl region.  Asp172 plays a key role in positioning of Arg301 to 
bind the carboxylate group of ADT.  First, Asp172 is hydrogen bonded to Arg248 
which positions the side chain carboxylate in plane with the guanidinium moiety of 
Arg301.  This in turn positions the guanidinium group to lie above the carboxylate of 
ADT with a geometry that favors strong hydrogen bonds.  Though Arg248 is not 
entirely conserved, it is either arginine or lysine, either of which could orient Asp172 
through a salt bridge.  Trp193 from one monomer forms π-stacking interactions with a 
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Figure 2.7. Sequence alignment of Thi4 from S. cerevisiae with 14 Thi4 orthologs.  
The Thi4 secondary structures are listed above the corresponding sequence.  Mostly 
conserved residues are colored pink, while those that are exclusively conserved are 
colored red. 
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Trp193 in another monomer and is buried amongst several aromatic residues, 
including Tyr56, Phe57, Phe113 and Phe165 from both chains.  Conservation of 
Trp193 is probably key in octomer stabilization.   
Mostly conserved Val170, Phe241, Phe244, Met291 and Gly303 interact with 
the ligand.  Both phenylalanine residues form π-stacking interactions with the adenine 
moiety of ADT.  Val170 contributes to hydrogen bonding interactions through its 
amide nitrogen and carbonyl oxygen atoms to N1 and N6 of the adenine ring, 
respectively.  Though this residue is not entirely conserved, all Thi4 orthologs contain 
a small hydrophobic residue in this position suggesting that a hydrophobic 
environment near the side chains is important for orienting the hydrogen bonding main 
chain atoms.  The methionine triad (Figure 2.4B) found in the helix-turn-helix motif 
encompassed by helices α8 and α9 is entirely conserved, with the exception of only 
one organism (Aeropyrum pernix) for which the equivalent of Met291 is isoleucine.  
None of the three methionine residues has significant side chain interactions with the 
exception of Met309, which forms a short contact of 3.3 Å between its sulfur atom and 
the bridging oxygen atom between the β-phosphate and the thiazole ring.  The reason 
for the high conservation of this methionine triad is currently unknown. 
Comparison with other protein structures   
A structural similarity search using DALI (17) revealed that all of the top hits 
belong to the glutathione reductase type II family fold (GR2) (18).  A summary of Z 
scores and structural overlaps for the top 10 structures from the DALI output are 
shown in Table 2.5.  The listed enzymes include phenol hydroxylase (PDB 1FOH), 
fumerate reductase (PDB, 1QJD) and the prokaryotic thiamin biosynthesis protein 
glycine oxidase (ThiO) (PDB, 1NG3), which have the same topology in the ADT 
binding region.  This GR2 family is characterized by a GxGxxG(x)nE/D sequence, 
where n can range from 16 to 19 residues in length.   This sequence in Thi4 
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corresponds to residues 72 to 97, where n = 20, and the 97th residue is an exclusively 
conserved glutamic acid.  The glutamic acid is responsible for hydrogen bonding to 
the 2′- and 3′- hydroxyl groups of the ribose sugar; a common feature in nucleotide  
Table 2.5. DALI search results 
a Total number of equivalent residues. 
b Positional root mean square deviation of superimposed Cα in Angstroms. 
c Percentage of sequence identity over equivalent positions. 
PDB Code Z-Score LALIa r.m.s.d.b %IDc 
1RP0 36.8 255 1.0 57% 
1QJD 17.5 212 3.5 18% 
1TRB 16.1 161 2.4 13% 
1HYU 16.1 181 8.4 14% 
1PBE 15.5 181 2.7 13% 
1KDG 15.4 193 2.6 21% 
1NG3 15.2 180 2.4 15% 
1QLA 15.1 198 2.8 20% 
1FOH 14.6 190 2.9 17% 
1B8S 14.3 196 2.9 13% 
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binding proteins.  The most unexpected result of Thi4 being a member of the GR2 
family is that every member to which Thi4 has a significant topological similarity via 
DALI is a flavoenzyme.  However, our recently published studies suggest that Thi4 
utilizes NAD as its substrate (6).  Classic NAD-dependent oxidoreductases such as 
alcohol dehydrogenase, lactate dehydrogenase and 3-glyceraldehyde-3-phosphate 
dehydrogenase exhibit a Rossmann fold characteristic of NAD binding proteins (19), 
but the fold in Thi4 has a clearly different topology (Figure 2.1B).   
A structural overlay between Thi4 and ThiO is shown in Figure 2.8.  The FAD 
binding domain between Thi4 and ThiO overlaps well, with the rest of ThiO having 
neither any similarity to the dimeric interface between Thi4 monomers or to another 
Thi4 monomer within the octomeric complex.  The ADT in Thi4 and FAD in ThiO 
overlap well in the ADP moiety, but diverge after the β-phosphate.  Thus the GR2 fold 
serves both as a cofactor binding topology for flavoenzymes and as a fold that can 
utilize NAD as a substrate to generate a critical component in yeast thiamin 
biosynthesis.  When considering Thi4 from an evolutionary standpoint, it represents an 
unprecedented scenario where a protein fold that once served to bind FAD as a 
cofactor evolved to bind and catalyze NAD as a substrate without any topological 
rearrangement. 
Mechanistic Implication  
Previous studies, using labeled precursors, have demonstrated that the thiazole 
heterocycle of thiamin is biosynthesized in yeast from glycine, cysteine and an 
unidentified C5 sugar (2-4). The Thi4 structure with ADT bound at the active site 
shows that the unidentified C5 sugar is linked to ADP. This observation suggests that 
the C5 sugar precursor to the thiazole is derived from an adenylated metabolite 
synthesized in both S. cerevisiae and in E. coli, such as NAD, NADH, FAD or FADH  
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Figure 2.8. Stereoview of a superposition of Thi4 and ThiO showing the overlapping 
dinucleotide binding domains.  Overlapping secondary structural elements are shown 
in blue (α-helices) or green (β-strands).  Non-overlapping secondary structural 
elements are shown in pink (Thi4) or gray (ThiO).  FAD bound to ThiO is shown as a 
black ball-and-stick model.  ADT bound to Thi4 is shown as a red ball-and-stick 
model. 
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Figure 2.9. Chemical structures of FAD, NAD and ADT.  Atoms common to all three 
structures are shown in red and the five carbon atoms corresponding to the thiazole are 
numbered.  The remaining atoms of the thiazole are derived from glycine and an 
unidentified sulfur donor. 
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(Figure 2.9).  NAD/NADH seems more likely than FAD/FADH because pyridine can 
be more readily cleaved from ribose than isoalloxazine from ribulose using an NAD-
glycohydrolase-like activity.  In addition, the pentose sugar of NAD is in the correct 
oxidation state to form the thiazole moiety, whereas in FAD/FADH it needs to be 
oxidized.  
While the structure of the yeast thiazole synthase identifies NAD as the most 
likely thiazole precursor and provides key insights into the mechanism of thiazole 
formation in eukaryotes, much still remains to be discovered about this interesting 
protein.  The mechanistic proposal outlined in Scheme 2 needs to be tested and refined 
and the sulfur source and the mechanism of sulfur transfer remain to be determined.  
Also the biological significance of the stable enzyme-product complex is unknown.  In 
addition, four other properties of Thi4 and its orthologs are worth mentioning.  In the 
exponential growth phase, Thi4 is an abundant protein (1.5% of the entire proteome) 
(20) in N. crassa, grown in the absence of thiamin.  Genetic studies indicate that the 
Arabidopsis Thi4 (Thi1) protects mitochondrial DNA from damage (21).  The N. 
crassa Thi4  (CyPBP37) is posttranslationally modified and forms a stable complex 
with a cyclophilin (NcCyP41) (22).  The Fusarium oxysporum Thi4 (sti35) is induced 
by various stress conditions (23).  These observations suggest that in addition to 
thiamin biosynthesis, Thi4 is likely to have additional functions in the cell 
Section 2.5 Conclusions 
Thiamin was the first vitamin discovered, but the last to have its biosynthesis 
elucidated, due to the novelty and complexity of its biosynthetic chemistry. While the 
major features of the bacterial pathway have now been elucidated, little is known 
about the biosynthesis of this important vitamin in eukaryotes. This paper describes 
the structure of the S. cerevisiae thiazole synthase (Thi4) with adenosine diphospho-5-
(β-ethyl)-4-methyl-thiazole-2-carboxylic acid (ADT) bound at its active site. The 
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isolation of this product identifies NAD as the most likely precursor to the thiamin 
thiazole, suggests that its biosynthesis is mechanistically related to protein ADP 
ribosylation, which is an important cellular regulatory process, and provides the first 
mechanistic insights into the biosynthesis of the thiamin thiazole in eukaryotes.  
Additionally, the Thi4 structure reveals the first protein structure with a GR2 domain 
that binds NAD instead of FAD, raising interesting questions about how this protein 
evolved from a flavoenzyme to an NAD binding enzyme.  
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CHAPTER THREE 
 
CRYSTAL STRUCTURE OF A SULFUR CARRIER PROTEIN COMPLEX 
FOUND IN THE CYSTEINE BIOSYNTHETIC PATHWAY OF 
MYCOBACTERIUM TUBERCULOSIS 
 
Section 3.1  Introduction 
CysM (Rv1336) and CysO (Rv1335) are two proteins that participate in a recently 
discovered cysteine biosynthesis pathway in Mycobacterium tuberculosis (1).  In this 
pathway CysO thiocarboxylate displaces the acetyl group of O-acetylserine in a 
reaction catalyzed by the pyridoxal 5′-phosphate (PLP) dependent CysM protein. An 
N-S acyl shift, followed by Mec+ (Rv1334) catalyzed hydrolysis generates cysteine 
(Figure 3.1).  This pathway stands in contrast to the widely used sulfide-dependent 
cysteine biosynthesis pathway also present in M. tuberculosis (CysK) and may be of 
importance in the oxidizing environment of the macrophage (2-6) because 
thiocarboxylates are much more resistant to oxidation than 
sulfide.   
 
 
 
 
 
Figure 3.1.  The new cysteine biosynthetic pathway in M. tuberculosis. 
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Consistent with this, the genes for CysM and CysO are upregulated when the 
organism is exposed to oxidative stress (7). 
Sulfur-carrier proteins are structurally homologous to ubiquitin (8) and have 
now been identified in the biosynthetic pathways for cysteine (1), thiamin (9), 
molybdopterin (10), and thioquinolobactin (11).  Like ubiquitin, the sulfur carrier 
protein is adenylated at a diglycyl C-terminus by a specific activating protein.  The 
adenylated C-terminus is subsequently converted to a thiocarboxylate, which serves as 
the sulfide source.  Members of the sulfur carrier protein family have diverse binding 
partners and show little sequence similarity.  ThiS is the sulfur carrier protein in 
thiamin biosynthesis and is activated by ThiF (12).  Thiocarboxylated-ThiS, deoxy-D-
xylulose 5-phosphate and glycine imine serve as substrates for ThiG in the synthesis 
of the thiazole moiety of thiamin (13).  The sulfur carrier protein MoaD is found in the 
molybdopterin biosynthetic pathway and its activating protein is MoeB (14).  Crystal 
structures for the ThiF-ThiS (15), ThiG-ThiS (16), MoeB-MoaD (17) and MoaE-
MoaD (10) complexes have been reported.  An interesting variation of a sulfur carrier 
protein is found in the biosynthetic pathway of thioquinolobactin (18).  In this system 
QbsE is the sulfur carrier protein and QbsC is the adenylating protein.  QbsE has a 
diglycyl sequence followed by cysteine and phenylalanine at its C-terminus.  
Clustered with the genes for these two proteins is a gene for QbsD, a metal-dependent 
hydrolase, which cleaves the final two amino acids from QbsE generating the diglycyl 
C-terminus found in all of the other sulfur-carrier proteins. 
We report here the X-ray crystal structure of the CysM-CysO complex of the 
cysteine biosynthetic pathway refined to 1.53 Å resolution, the structure of CysM 
alone at 2.8 Å resolution, and the structure of CysO alone at 2.7 Å resolution.  The 
CysM-CysO complex is asymmetric with one molecule of CysO binding to one end of 
a CysM dimer.  Conformational changes in CysM that occur upon complex formation 
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are described.  The CysM-CysO interface is compared to the binding interfaces for 
ThiF-ThiS, ThiG-ThiS, MoeB-MoaD, MoaE-MoaD and ubiquitin in complex with the 
E1-like protein MMS2. 
Section 3.2 Materials and Methods 
Gene Cloning, Overexpression and Purification 
M. tuberculosis DNA was a gift from Clifton Barry at the National Institutes of 
Health.  pET-16b and pET-28a plasmids were purchased from Novagen.  All plasmid 
DNA was purified with a DNA miniprep kit from Promega.  A Perkin Elmer 
GeneAmp PCR system 2400 and Platinum Pfx DNA polymerase (Gibco Life 
Technologies) were used for PCR.  Primers were purchased from Inegrated DNA 
Technologies. Oligonucleotides were prepared using M. tuberculosis DNA as a 
template for PCR, and sequencing was performed by the Bioresource Center at 
Cornell University.  DNA fragments were purified by agarose gel electrophoresis 
followed by a QIAquick gel extraction kit from Qiagen.  T4 DNA ligase was 
purchased from New England Biolabs.  Escherichia coli strain DH5α was used as a 
recipient for transformation, propagation, and storage.  Primers for the CysM plasmid 
were engineered to introduce NdeI and BamHI restriction sites at the 5′ and 3′ ends, 
respectively.  The forward primer was 5′-GGG TGA GCG GAG CAT ATG ACA 
CGA TAC GAC-3′.  The reverse primer was 5′-TTC GGA TCC GGC GGA TCC 
TCA TGC CCA TAG-3′. Primers for the CysO plasmid were engineered to introduce 
NdeI and XhoI restriction sites at the 5′ and 3′ ends, respectively.  The forward primer 
was 5′-CCG AGA AAG GCC CAT ATG AAC GTC ACC GTA-3′.  The reverse 
primer was 5′-TCG TGT CAT GTG CTC GAG TCA CCC ACC GGC-3′.   
The CysM construct was transformed into B834(DE3) methionine auxotrophic 
E. coli (Novagen) for overexpression.  Minimal media used for overexpression of 
B834(DE3) cells was prepared by dissolving 11.28 g of M9 salts along with 40 mg/L 
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of each amino acid excluding methionine, which was replaced by selenomethionine at 
50 mg/L.  The final media also contained 0.4% (w/v%) glucose, 0.1 mM CaCl2, 2 mM 
MgSO4, 25 mg/mL FeSO4, 100 mg/L ampicillin and 10 mL of 100x MEM vitamin 
solution (Invitrogen).  Starter cultures were prepared by growing cells in 20 mL of LB 
media, then spinning the cells at 4800g for 5 min.  The LB supernatant was decanted 
and the cell pellet resuspended with 20 mL of minimal media to inoculate 1 L of 
minimal media.  Cells were grown at 37 °C until an OD600 of 1.0 was reached, 
followed by induction using 1 mM isopropyl-β-D-thiogalactopyranoside for 16-18 h at 
18 °C.  Cell pellets were collected by centrifugation at 6400g for seven minutes, and 
placed into a beaker containing 50 mL of a lysis buffer composed of 5 mM imidazole, 
0.5 M NaCl and 20 mM Tris at pH 7.9 to be lysed using sonication.  Cell lysate was 
separated from the insoluble cell particles by centrifugation at 58,000g at 4 °C for 20 
min. The supernatant was run over a Ni-NTA affinity column equilibrated with lysis 
buffer.  The column was washed with lysis buffer containing 60 mM imidazole and 
eluted with lysis buffer containing 1M imidazole.  The eluate was buffer exchanged 
into 20 mM pH 7.9 Tris and 5 mM 1,4-dithiothreitol (DTT) using size exclusion 
chromatography columns (Bio-Rad DG) with a molecular weight cut off of 6 kDa.  A 
centrifugal filter (Amicon Ultra) with a molecular weight cut off of 10 kDa was used 
to concentrate the solution by spinning at 5,000g at 4 °C.  The final protein 
concentration was 10-20 mg/mL as measured using the Bradford Assay (19).  SDS-
PAGE analysis showed a purity of greater than 95%.  Native CysM and CysO were 
transformed into BL21(DE3) cells, overexpressed in LB media and purified as 
described above, without the use of DTT.   
In an attempt to improve crystallization, a putative surface residue in CysM 
(Lys204) was mutated to alanine using site-directed mutagenesis (20).  A standard 
PCR protocol using PfuTurbo DNA polymerase per the manufacturer’s instructions 
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(Invitrogen) and DpnI (New England Biolabs) to digest the methylated parental DNA 
prior to transformation was used.  The forward primer was 5´- GCA CGT TGC CAA 
CGT CGC GAT CGT GGC GGC CGA ACC CCG C-3´ and the reverse primer was 
5´- GCG GGG TTC GGC CGC CAC GAT CGC GAC GTT GGC AAC GTG C-3´.  
Clones were screened by restriction digest for the introduction of a PvuI site.  A 
representative clone with the correct restriction pattern was sequenced by the 
Bioresource Center at Cornell University. 
Protein Crystallization and Cryoprotection  
A solution of native CysM-CysO was prepared by mixing separate 15 mg/mL 
solutions each of CysO and CysM in a 2:1 volumetric ratio.  This solution was 
screened using the hanging drop vapor diffusion method.  Individual crystals grew in a 
range of 7-10% PEG 4,000 (wt/v%), 0.1 M sodium citrate pH 5.8 and 0.2 M 
ammonium acetate at 22 °C.  Selenomethionine crystals grew in the same conditions 
with 5 mM DTT.  Crystals were green in color and grew to 150 x 150 x 50 µm3 within 
two to four weeks.  The K204 mutant was also screened using the hanging drop 
method with a 10 mg/mL protein solution.  Crystals of the K204A mutant grew to 
approximately 100 x 40 x 20 µm3 in two to four weeks using the hanging drop method 
in 0.1 M HEPES pH 7.1 and 0.64 M Li2SO4 at 22 °C.  Crystals of CysO were grown 
using the hanging drop method in the presence of the activating protein MoeZ 
(Rv3206). A solution of native MoeZ-CysO was prepared by mixing separate 10 
mg/mL solutions each of MoeZ and CysO in a 1:1 volumetric ratio.  Crystals appeared 
in 0.2 M NaNO3 and 20% (wt/v%) PEG 3350 after approximately six months as 
colorless thick plates with dimensions of 200 x 40 x 40 µm3.  Preliminary analysis of 
the X-ray diffraction data showed that these crystals contained only CysO. 
 Cryoprotection of the CysM-CysO complex and CysM K204A mutant crystals 
was carried out through sequential dipping into well solutions with increasing 
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concentrations of ethylene glycol.  The cryosolution for the selenomethionine 
derivative and native CysM-CysO crystals contained 9% PEG 4000, 0.1 M sodium 
citrate pH 5.8, 0.2 M ammonium acetate, 1 mM DTT and either 5% or 25% ethylene 
glycol by volume.  Crystals were first looped out of the mother liquor, and then placed 
in the 5% ethylene glycol solution for approximately 10 s, followed by dipping into 
the 25% ethylene glycol solution for another 10 s.  The crystal was then looped out of 
the 25% solution and plunged into liquid nitrogen for storage.  Cryoprotection of the 
K204A CysM mutant was also done using sequentially increasing concentrations of 
ethylene glycol.  CysM crystals were first dipped into a solution with 5% ethylene 
glycol, 0.64 M Li2SO4, and 0.1 M HEPES pH 7.1 followed by dipping into the same 
cryosolution with 25% ethylene glycol for approximately 10 s each.  Crystals of CysO 
were cryoprotected by dipping into a solution of 0.2 NaNO3, 20% PEG 3350 and 25% 
PEG 400 for approximately 10 s before plunging into liquid nitrogen.   
X-ray Data Collection 
Data for the selenomethionine derivative CysM-CysO crystal were collected at 
the 24-ID-C beamline at the Advanced Photon Source to 2.1 Å resolution.  The energy 
was calibrated with Se foil, and an X-ray fluorescence scan was done on the CysM-
CysO crystal to determine the absorption edge.  Images were taken using a Quantum 
ADSC Q315 detector (Area Detectors Systems Corp.) for 720 frames with 1° 
oscillations in 10° wedges.  Native data for the CysM K204A and CysM-CysO 
complex crystals were collected at the 8-BM beamline at APS using 1° oscillations for 
140° and 300°, respectively, using a Quantum ADSC Q315 detector.  Data for the 
CysO crystals were collected using a Rigaku RTP 300 RC rotating copper anode 
generator operating at 50 kV and 100 mA.  A Rigaku RAXIS IV++ image plate 
detector was used for image detection.  Data collection was done in 1° oscillations for 
a total of 215°.  Data collection statistics for all datasets are summarized in Table 3.1.   
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Table 3.1. Data Collection Statistics 
Sample 
SeMet 
CysOM 
Native 
CysOM1 
K204A 
CysM 
Native 
CysO 
Source APS 24ID APS 8BM APS 8BM Home 
Wavelength (Å) 0.97950 0.97949 0.94980 1.54178 
Resolution (Å) 2.10 1.53 2.80 2.70 
Space group P21 P21 P212121 C2 
Unit-cell 
parameters 
    
a (Å) 56.2 55.8 72.4 87.9 
b (Å) 80.6 80.4 85.4 62.9 
c (Å) 91.5 89.6 98.9 36.5 
β (°) 106.8 105.8 90 114.6 
No. of 
reflections 
650381 334177 875722 20088 
No. of unique 
reflections 
45147 110648 15513 5022 
Redundancy 14.4(12.0) 3.0(2.5) 5.5(5.3) 4.0(3.0) 
Completeness 98.9(92.5) 96.3(81.6) 99.6(96.2) 99.2(95.4) 
Rsym2(%) 7.8(30.9) 4.6(21.9) 8.0(24.7) 14.5(39.2) 
I/σ(I) 40.1(6.6) 26.2(4.0) 18.6(4.1) 14.5(3.5) 
1 Merged with low resolution data from SeMet crystal. 
2 Rsym = ΣΣi| Ii - <I> |/Σ<I>, where <I> is the mean intensity of the N reflections with 
intensities Ii and common indices hkl. 
Numbers in parentheses represent the highest resolution shell. 
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Integration and scaling of all data was done using the HKL2000 suite of programs 
(21).    
Structure Determination and Refinement 
Selenium sites in the selenomethionine derivative CysM-CysO crystal were 
found using SOLVE (22), with 11 of the 14 possible selenium peaks located.  Density 
modification (23) and automated model building (24) was done using RESOLVE.  
The remainder of the model was built using the graphics programs O (25) and Coot 
(26).  Refinement was carried out using the CCP4 (27) and CNS (28) suite of 
programs.  The selenomethionine derivative structure was then refined against the 
higher resolution native CysM-CysO data.  The native CysM-CysO dataset had low 
completeness in the resolution range of 6 Å and below due to intensity overloads.  To 
account for this, the native CysM-CysO dataset was merged with data corresponding 
to a resolution of 6 Å and below from the selenomethionine derivative crystal in 
Scalepack (21) for refinement and map calculations.  In the final stages of refinement, 
the high resolution data alone were used to refine the model.  All residues in all three 
molecules were modeled into the electron density with the exception of the N-terminal 
methionine residue of CysO and residues 126-129 in the CysM chain that does not 
interact with CysO (CysMB).  Six residues were modeled in alternate conformations: 
Leu169 from the CysM molecule that interacts with CysO (CysMA), Cys99, Met190, 
Thr257 and Leu270 from CysMB and Thr9 from CysO. 
The structure of CysMA was used as an initial model to refine against the 
K204A CysM data.  Residues 212-226 and 315-323 from chain A and 313-326 from 
chain B were not modeled due to disorder in the electron density maps.  The refined 
structure of CysO from the CysM-CysO complex was used as an initial model to 
refine the CysO only data.  All but residues 91-93 were built into the model.  The final  
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Table 3.2. Refinement Statistics 
Sample 
SeMet 
CysOM 
Native 
CysOM 
K204A 
CysM 
Native 
CysO 
No. of non-H atoms 5529 6512 4648 1290 
No. of protein atoms 5150 5454 4443 1266 
No. of water atoms 349 1028 160 24 
No. of ligand atoms 30 30 45 0 
Rworking (%)3 19.2 17.6 19.0 19.5 
Rfree (%)4 24.3 21.7 25.6 25.2 
Ramachandran plot     
Most favored region (%) 89.7 91.7 89.4 89.0 
Additionally allowed 
regions (%) 
7.5 7.9 8.6 11.0 
Generously allowed 
region (%) 
1.9 0.3 1.6 0.0 
Disallowed region (%) 0.9 0.0 0.4 0.0 
R.M.S. deviations from 
ideal 
    
Bonds (Å) 0.021 0.026 0.021 0.019 
Angles (°) 2.0 2.2 2.0 2.0 
3 Rworking= Σ||Fobs | - K|Fcalc||/Σhkl|Fobs|, where Fobs and Fcalc are the observed and calculated 
structure factors, respectively 
4 Rfree was calculated using 5% of all reflections that were excluded at all stages of 
refinement 
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refinement statistics for all datasets and the geometries and distances of all final 
models as evaluated by PROCHECK (29) are shown in Table 3.2.  
Molecular Modeling of Intermediates   
The program MacroModel, version 9.1 (30, 31) was used to model both the O-
acetylserine (OAS)-PLP adduct 3, the α-aminoacrylate intermediate 5 and 
intermediate 6.  All water molecules were removed from the structure and the C-
terminus of CysO was converted to a thiocarboxylate and manually adjusted to point 
toward the active site.  Hydrogen atoms were added where appropriate.  The initial 
position of each intermediate was approximated by overlaying the structure of O-
acetylserine sulfhydrylase from Salmonella typhimurium containing an external 
aldimine linkage to methionine (32) with CysM and superimposing their respective 
aldimine Cα and carboxylate atoms.  Modeling was carried out using a 20 Å shell 
surrounding the OAS moiety of the adduct, with residues within a 6 Å shell allowed to 
move and the remaining residues frozen.  Some of the key residues in the 
conformational search included 91-AGG-93 from CysO, and 184-GTTGT-188, Lys51, 
Ser265 and 322-WA-323 from CysM.  Torsional rotation was allowed between all 
atoms within the PLP-OAS adduct connected by a single bond in the conformational 
search parameters.  Modeling was done using the AMBER* force field (33, 34) and a 
distance dependent electrostatic treatment with a dielectic constant of 4.0.  The TNCG 
minimization method was used for the energy minimization of structures generated by 
conformational search (35).  Conformational searching with the α-aminoacrylate 
intermediate was done in the same way.  The final models were manually adjusted to 
optimize the expected reaction geometry. 
Figure Preparation   
All figures of protein molecules and residues were generated in PyMOL (36). 
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Section 3.3  Results 
CysM Structure   
The CysM molecule is composed of eight α-helices, five 310-helices and nine β-
strands (Figure 3.2A and B).  The protomer has a large and a small domain, each with 
an αβα sandwich fold.  The large domain has a mixed β-sheet with 
β1↑β2↓β9↓β6↓β7↓β8↓ topology, while the smaller domain consists of a three-
stranded parallel β-sheet comprised of strands β3, β4 and β5.  This topology is 
consistent with other β-elimination enzymes (37).  The interface between CysM 
molecules consists of loop regions with 60% of the residues being hydrophobic at the 
dimer interface. Other interactions include a salt bridge between Arg3 and Glu175 and 
a series of hydrogen bonding pairs that are listed in Table 3.3. 
Table 3.3. Dimeric Interactions 
A Chain      B Chain    H-bond Atoms 
Thr2 Asp172 OH−Oδ 
Tyr4 Leu16 NH−O 
Tyr4 Gly18 O−NH 
Asp5 Gln20 O−NHε 
Leu92 Arg21 O−NH1 
Gln111 Leu301 NHε−O 
Leu115 His256 O−NHε 
Tyr116 Gly259 OH−O 
Asp172 Arg3 O−NH1 
Glu175 Arg3 Oε−NH1 
His256 Arg91 O−Nε 
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Figure 3.2.  Structures of CysM and CysO.  (A)  CysM ribbon diagram.  (B) CysM 
topology.  (C) CysO ribbon diagram. (D) CysO topology diagram.  (E)  Ribbon 
diagram of the CysM-CysO complex.  CysM bound to CysO (CysMA) is color coded 
with red helices, yellow strands and green loops. CysO and CysM not bound to CysO 
(CysMB) are color coded with cyan helices, magenta strands and salmon loops.   
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CysO Structure   
The CysO monomer is 93 residues in length and 9.6 kDa in mass.  The 
secondary structure consists of two 310 helices, a mixed four-stranded β-sheet with a 
β3↑β4↓β1↓β2↑ topology and one α-helix inserted between β2 and β3 (Figure 3.2C 
and D).  This topology describes the β-grasp fold that is seen in the sulfur carrier 
proteins ThiS (15) and MoaD (17) as well as ubiquitin (38). 
CysM-CysO Complex   
The asymmetric CysM-CysO complex consists of a CysM dimer with a CysO 
molecule bound to one end (CysMA denotes the protomer interacting with CysO and 
CysMB denotes the unbound protomer) (Figure 3.2E).  The CysMA and CysMB 
protomers show two main differences.  First, the loop region spanning residues 211-
237 in CysMA contains three 310 helices, and extends away from the core of the 
structure to accommodate CysO binding.  CysMB adopts a more compact structure 
with an α-helix spanning residues 217-222 and a single 310 helix spanning residues 
228-231.  Second, the smaller domain comprising strands β3, β4 and β5 and helix α4 
is shifted away from the core of the complex structure.  Only the conformation of the 
CysO binding loop in CysMA allows for hydrogen bonds to form between the region 
connecting β5 and α4 in the smaller domain.  The hydrogen bonds that contribute to 
this shift in CysMA are between the carboxylic acid side chain from Glu126 and the 
carbonyl oxygen atom of Ala218 and between the amide nitrogen atom of Gly217 and 
the carbonyl oxygen atom of Val216.  
The comparison between CysO molecules from the complex structure and the 
CysO alone structure shows that the overall structure remains the same, with a root-
mean-square deviation (r.m.s.d.) between 89 Cα carbon atoms of 0.5 Å.  One main 
difference is that the C-terminus of CysO in the complex is well ordered through 
several hydrogen bonds with CysM.  The absence of CysM binding leads to disorder 
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in the final three residues of CysO alone, which were not modeled into the structure.  
25% of the accessible surface of CysO is buried in the complex as calculated by the 
protein-protein interaction server (39).  Key hydrogen bonds between CysO and CysM 
are listed in Table 3.4.  The side chain oxygen atom of Asp65CysO is hydrogen bonded 
to His271A through a bridging water molecule (subscripts CysO and A refer to CysO 
and CysMA, respectively).  A bridging water molecule is found donating hydrogen 
bonds to the carbonyl oxygen atoms of both Gly92CysO and Leu183A, and two bridging 
water molecules form a hydrogen bonding network connecting the carbonyl oxygen 
atoms of Val90CysO and Phe226A.  Two salt bridges also occur at the protein-protein 
interface between Arg12CysO and Glu214A, and Asp65CysO and Arg211A.  
Table 3.4. CysM-CysO Hydrogen Bonds 
   CysM         CysO    H-bond Atoms 
Asn130 Ala89 NHδ−O 
Asn130 Ala91 Oε−ΗΝ 
Glu209 Tyr62 Oε−ΗΟ 
Tyr217 Gly93 OH−Ο 
Phe226 Ala89 NH−O 
Arg239 Asp67 O−HN 
Ser241 Asp65 OH−Oδ 
Active Site 
A PLP cofactor is found in each protomer of CysM covalently attached to 
Lys51 through a Schiff base linkage.  Figure 3.3 illustrates key interactions between 
CysM and PLP.  A glycine and threonine rich sequence binds the phosphate group, 
and is characteristic of PLP binding proteins (40).  A large area of open space 
occupied only by water molecules spans the distance between Gly93 of CysO and the 
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PLP molecule.  The distance from the Schiff base forming carbon atom of PLP to the 
closest C-terminal oxygen atom of CysO is 11.3 Å.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.  CysM active site with PLP coordinating residues labeled with green 
carbon atoms. 
 
 
 
 
 63 
Molecular Modeling   
Molecular modeling simulations using conformational searching followed by 
molecular mechanics based energy minimization, followed by manual oprimization, 
were carried out using MacroModel for both the PLP-OAS adduct 3 and the α-
aminoacrylate intermediate 5 in the active site.  In the PLP-OAS model (Figure 3.4A), 
the carboxylate moiety of OAS accepts a hydrogen bond from the amino side chain of 
Asn81.  One oxygen atom of the acetate moiety accepts a hydrogen bond from the 
hydroxyl group of Tyr212 while the other accepts a hydrogen bond from the amide 
nitrogen atom of Ala323.  In the α-aminoacrylate model (Figure 3.4B), the 
carboxylate moiety accepts hydrogen bonds from the hydroxyl group of Tyr212 and 
the amide nitrogen atom of Ala323 as well.  The conformation of the C-terminus of 
CysO shows the sulfur atom at a distance of 3.7 Å from the β-carbon α-aminoacrylate 
intermediate 5.  Using the aminoacrylate as a starting point, a model for the 
subsequent intermediate 6 in which the carbon-sulfur bond has formed was generated 
(Figure 3.4C).  
Section 3.4  Discussion  
CysM and Structural Homologues   
Structural homologues were identified using the DALI server (www.ebi.ac.uk/dali) 
and the top hits were selected for comparison (Table 3.5).  The closest structural 
homolouges are β-elimination enzymes, which use OAS or phosphoserine as a 
substrate to make cysteine.  CysK, the sulfide-dependent cysteine synthase, has 
r.m.s.d. values of 2.4 Å for 281 Cα carbon atoms from CysMA and 1.8 Å for 278 Cα 
carbon atoms from CysMB.  S. typhimurium O-acetylserine sulfhydrylase (OASS) has 
r.m.s.d. values of 2.5 Å for 287 Cα carbon atoms from CysMA and 1.9 Å for 283 Cα 
carbon atoms from CysMB.  The conformation of the CysO binding loop of CysM is 
the most significant difference between the structural homologues, which do not bind 
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a sulfur-carrier protein.  The conformation of the binding loop in CysMB is more 
similar to  
Table 3.5. CysM Structural Homologues  
PDB Code 
Z-
Score 
Aligned Cα atoms r.m.s.d. Annotation 
2Q3B 34.8 281 2.4 cysteine synthase 
1OAS 34.2 287 2.5 O-acetylserine sulfhydrylase 
1WKV 32.7 278 2.0 O-phosphoserine sulfhydrylase 
2TYS 27.9 274 2.7 tryptophan synthase 
1TDJ 25.9 271 2.9 threonine deaminase 
1V71 24.7 267 3.2 serine racemase 
1PWE 23.9 264 3.4 serine dehydratase 
1F2D 22.9 262 2.7 
1-aminocyclopropane- 
1-carboxylate deaminase 
1E5X 21.7 269 3.6 threonine synthase 
1KL7 20.7 269 3.5 threonine synthase 
the structural homologues than in CysMA, which results in the lower r.m.s.d. values.  
Another structural difference is that the C-terminal tail of CysM encompassing 
residues 300-323 contains two 310 helices and points directly into the active site.  Both 
the CysK and OASS structures lack this N-terminal extension.   
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Figure 3.4.  Stereoviews of the active site models.   (A) The PLP-OAS adduct 3.  (B) 
α-aminoacrylate intermediate 5.  (C) Intermediate 6 in which the C-S bond has 
formed.  CysM residues are labeled with magenta carbon atoms, CysO residues are 
labeled with green carbon atoms and PLP and OAS or aminoacrylate moieties with 
cyan carbon atoms. 
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CysM and CysK Active Site  
The PLP binding geometry of CysM and CysK are very similar (Figure 3.5A 
and B).  The final two residues of CysM, Trp322 and Ala323, point toward the active 
site of the protein.  A π-stacking interaction between Trp322 and Tyr212 helps to 
position the C-terminus.  Residues 218-222, rather than the C-terminus, occupy this 
region in CysK.  These residues correspond to the CysO binding loop of CysM based 
on sequence alignment.  Additionally, there is a molecule of 2-methyl-2,4-pentanediol 
in CysK corresponding to the region of CysM spanning the C-terminus of CysO and 
the PLP cofactor.  The C-terminus of the CysM K204A mutant also does not point to 
the active site.  However, the CysO binding loop of one of the K204A protomers is 
seen ordered and has the same conformation as the corresponding residues in CysK. 
CysO and Structural Homologues   
Structural homologues were identified using the DALI server and selecting the 
top hits for comparison (Table 3.6).  The β-grasp proteins complexed with a binding 
partner were also used for comparison.  This included ThiS, MoaD and ubiquitin, 
which were compared to CysO through structural superposition.  Each possesses the 
same topology, with most structural differences found in loop regions rather than 
secondary structural elements (Figure 3.6).  CysO has insertions spanning residues 7-
19 and 48-55, which are absent in the homologues.  The exception is MoaD, which 
aligns well with residues 7-19 in CysO.  Both CysO and MoaD form a key binding 
interaction with their respective binding partner in this region.  The r.m.s.d. values 
between Cα positions in CysO are 2.6 Å for ThiS for 58 Cα carbon atoms, 2.8 Å for 
MoaD for 77 Cα carbon atoms and 2.6 Å for ubiquitin for 62 Cα carbon atoms. 
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Figure 3.5.  Schematic representation of CysM (A) and CysK (B) binding interactions 
with the PLP cofactor. 
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Table 3.6. CysO Structural Homologues  
PDB Code Z-Score Aligned Cα atoms r.m.s.d. Annotation 
1V8C 14.9 
86 1.8 Thermus thermophilus – 
MoaD 
1FMA 9.5 
78 2.3 MoaD from MoaE–MoaD 
Complex 
1JW9 8.9 
77 2.8 MoaD from MoeB–MoaD 
Complex 
2GLE 8.9 82 2.9 Neurabin SAM domain 
1XO3 8.1 80 2.9 Mus musculus – Urm1 
2BB5 7.9 78 2.6 Transcobalamin II   
1C1Y 5.4 
63 2.5 Ras-binding domain of c-
Raf1 
1ZUD 5.1 
58 2.6 ThiS from ThiF–ThiS 
Complex 
1TYG 4.7 
59 3.2 ThiS from ThiG–ThiS 
Complex 
1ZGU 4.4 
62 2.6 Ubiquitin from MMS2–Ub 
Complex 
CysM-CysO: Interactions and Conserved Residues  
 The features required for interactions with CysO come from three main 
sections of the CysM molecule.  First is the CysO binding loop encompassing residues 
211-237, which contributes the majority of CysO binding interactions.  Second is helix 
α4, which is part of the smaller domain of the CysM molecule.  Asn130 from this 
helix forms one of the key hydrogen bonds that stabilizes the C-terminal region of 
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CysO.  Third, strand β8 forms hydrogen bonds with the loop that proceeds from the β3 
strand of CysO.   
In order to determine key CysM residues, sequence alignments were performed 
using both homologues that utilize sulfur carrier proteins and ones that incorporate 
sulfur directly from sulfide.  Residues Asn81 and Ser265 that bind the PLP cofactor 
are exclusively conserved in both types.  The glycine and threonine rich sequence that 
binds the phosphate group of the cofactor varies slightly in the position of glycine and 
 
 
 
 
 
 
 
 
 
Figure 3.6.  Ribbon diagrams of all known sulfur carrier proteins and ubiquitin. 
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threonine or serine residues, but overall the motif is conserved.  A sequence alignment 
of 200 non-redundant CysM sequences shows that none of the residues on the CysM 
surface involved with CysO binding are conserved.  When the alignment is restricted 
to the organisms M. vanbaalenii, M. smegmatis, M. ulcerans and M. flavescens, all of 
which have both CysO and CysM genes, the CysO binding residues are exclusively 
conserved. Conservation of the CysM-CysO binding interface is maintained within the 
mycobacterium genus, but shows greater variation, especially in CysM, for other 
species. 
Comparison of the CysM-CysO Interface with Other β-grasp Protein Complexes   
In order to determine if regions of CysM and CysO involved in protein-protein 
interactions are similar to other β-grasp protein complexes, the structures ThiF-ThiS 
(15) ThiG-ThiS (16), MoeB-MoaD (17), MoaE-MoaD (10) and ubiquitin in complex 
with the E2-like protein MMS2 (41) were compared in Figure 3.7.  Table 3.7 lists 
several properties of the sulfur carrier proteins and ubiquitin at the protein-protein 
interface.  The percent of hydrophobic residues at the interface ranges from 61-72% 
for the sulfur carrier protein examples, while the ubiquitin-MMS2 structure falls 
below this range at 58%.  The number of hydrogen bonds between sulfur carrier 
proteins and their binding partners range from nine to 11, but ubiquitin-MMS2 
structure has only five.  This is due to ubiquitin having much less of its accessible 
surface area in close contact with its binding partner.  In the sulfur carrier protein 
examples, 20-25% of the accessible surface area is in close contact with each binding 
partner.  In ubiquitin, only 13% of the surface makes up the binding interface with 
MMS2.   
Structural alignments were made by superimposing each sulfur carrier protein 
or ubiquitin complex using only CysO as the template.  No structural similarities 
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Figure 3.7.  Ribbon and surface interface diagrams of CysM-CysO.  (A) ThiF-ThiS 
complex.  (B) ThiG-ThiS complex.  (C) MoeB-MoaD complex.  (D) MoaE-MoaD 
complex.  (E) Ubiquitin-MMS2 complex.  Sulfur carrier proteins and their respective 
binding partners are colored orange and light blue, respectively, in the areas that do 
not contribute to the binding interface.  The silver colored regions in both proteins 
indicate the area that makes up the binding interface. 
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Table 3.7. Protein-Protein Interface Comparisons 
Protein 
Interface 
Parameter 
CysO-
CysM 
ThiS-
ThiF 
ThiS-
ThiG 
MoaD-
MoaB 
MoaD-
MoaE 
Ub-
MMS2 
Interface 
Accessible 
Surface Area 
(Å2) 
1213.6 1045.9 1194.2 1113.2 985.1 632.4 
% Interface 
Accessible 
Surface Area 
24.6 22.7 24.2 23.5 19.7 13.4 
% Polar Atoms 
in Interface 
35.1 38.2 28.2 35.4 39.3 42.2 
% Non-Polar 
Atoms in 
Interface 
64.8 61.7 71.7 64.6 60.6 57.8 
Hydrogen 
Bonds 
11 14 11 9 13 5 
Salt Bridges 1 1 0 1 0 0 
between CysM, ThiG, MoaE or MMS2 are observed.  However, two β-strands 
between CysM, ThiF and MoeB align when each sulfur carrier protein is overlaid.  
The strands β7 and β8 in CysM align with strands β6 and β7 in ThiF and MoeB 
despite the fact that CysM has a different fold.  The regions in the sulfur carrier 
proteins and ubiquitin that make up most of the binding interface come from strands 
β3, β4 and the residues following β4 to the C-terminus.  The ubiquitin complex 
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structure has the smallest interface with only residue 42 from strand β3 and residue 68 
from β4 contributing to hydrogen bonds at the interface. 
Mechanistic Implications   
Based on the extensive mechanistic characterization of the sulfide-dependent 
cysteine synthase (42) a mechanistic proposal for the CysO/CysM-catalyzed reaction 
is outlined in Scheme 1.  In this proposal, O-acetyl serine forms an imine with PLP, 
which then undergoes a deprotonation to give 4.  Acetate elimination followed by 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.1 
thiocarboxylate addition to the resulting aminoacrylate gives 6.  The reaction scheme 
is completed by a tautomerization to 7, and a transimination reaction with Lys51 to 
release thioester 8, which undergoes an N/S acyl shift to give cysteinyl-CysO.  
The structural studies reported here are consistent with this mechanistic 
proposal. PLP is bound at the active site via an imine with Lys51.  The model of the 
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enzyme substrate complex shown in Figure 3.4A shows that the carboxy terminal 
sulfur of CysO thiocarboxylate is suitably positioned for addition to the β-carbon of 
O-acetyl serine (separation ~3.7 Å), that the acetyl group is activated as a leaving 
group by hydrogen bonding to an oxyanion hole comprising of the hydroxyl of 
Tyr212, and that the amide NH of Ala323.  Lys51 is the likely base mediating the 
deprotonation that converts 3 to 4.  The model of the aminoacrylate intermediate 
shown in Figure 3.4B is also consistent with our mechanistic proposal.  In this model, 
the carboxylate of the aminoacrylate 5 has moved into the oxyanion hole vacated by 
the departure of acetate further activating the aminoacrylate for addition of the 
thiocarboxylate sulfur.   
Section 3.5  Conclusion  
The structure of CysM-CysO is an example of a β-elimination enzyme in complex 
with a sulfur carrier protein used to generate the amino acid cysteine.  CysM is able to 
bind CysO using a binding loop that is ordered differently in structural comparators 
and when CysO is unbound.  The binding loop contains residues that are only 
conserved among other species within the mycobacterium genus that also utilize a 
sulfur carrier protein for catalysis.  The overall fold of CysO is similar to that of other 
sulfur carrier proteins and ubiquitin.  Two β-strands at the interface of CysO and 
CysM are structurally aligned when compared to the E1 adenyltransferase proteins 
ThiF and MoaD.  Modeling studies show that the C-terminus of CysO is able to reach 
the β carbon of the α-aminoacrylate intermediate in a conformation favorable for 
nucleophilic addition.  
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CHAPTER FOUR 
CRYSTAL STRUCTURE OF A PURINE NUCLEOSIDE PHOSPHORYLASE 
(TM1596) FROM THERMOTOGA MARITIMA AT 2.01 Å RESOLUTION 
 
Section 4.1  Introduction   
The crystal structure of a trimeric purine nucleoside phosphorylase (PNP) from 
Thermotoga maritima (TmPNP; Tm1596) has been solved to 2.01 Å using X-ray 
crystallography.  The structure reveals a bound guanine base surrounded by residues 
that are highly conserved among PNP orthologs.  PNP enzymes have been well 
characterized biochemically (1), and X-ray crystal structures have been solved in both 
eukaryotic and prokaryotic systems (2).  The structure of a PNP enzyme from a 
thermophilic organism provides insight into the thermostability of the enzyme when 
compared to a mesophilic counterpart, which in this communication will be the X-ray 
crystal structure of PNP from Bos Taurus (bPNP).  Recent review articles discuss 
some of the factors which contribute to thermostability, and how these compare to 
mesophilic enzymes that catalyze the same reactions (3, 4).  In this communication, 
we will highlight the structural characteristics that differ between these two proteins 
and how that contributes to the greater thermostability of TmPNP over bPNP. 
Section 4.2 Materials and Methods  
Protein crystals were grown and data collected by the Joint Center for Structural 
Genomics.  Data collection statistics can be seen in Table 4.1. 
 The structure of TmPNP was solved using the method of molecular 
replacement with bPNP (PDB code 1PBN) as the molecular replacement search 
model.  Cross-rotational and translation searching were performed using CNS (5).  
Rigid body refinement and simulated annealing were performed before calculating the 
2Fo-Fc and simulated annealing composite omit electron density maps.  Model 
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Table 4.1. Data collection and Refinement Statistics 
Resolution (Å) 2.01 
Space group P1 
a, b, c 46.48 Å, 74.60 Å, 74.59 Å 
α, β, γ 117.34°, 100.95°, 100.71° 
No. of reflections 203633 
No. of unique reflections 54061 
Redundancy 3.8 (3.4) 
Completeness (%) 97.7 (93.8) 
Rsym a (%) 10.6 (52.2) 
I/σ(I) 12.9 (2.6) 
No. of non-H atoms 5969 
No. of protein atoms 5600 
No. of water atoms 335 
No. of ligand atoms 34 
R factor (%) b 20.4 
Rfree (%) c 24.0 
Ramachandran plot 
Most favored region (%)  
Additionally allowed regions (%)  
Generously allowed region (%)  
Disallowed region (%)  
r.m.s.d. from ideal 
Bonds (Å) 0.017 
Angles (°) 1.615 
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Table 4.1. con’t Data collection and Refinement Statistics 
 a Rsym = ΣΣi  | Ii - <I> | / Σ<I>, where <I> is the mean intensity of the 
N reflections with intensities Ii and common indices hkl. 
b R factor = Σ | |Fobs| - K|Fcalc| | / Σhkl |Fobs|, where Fobs and Fcalc are the observed and 
calculated structure factors, respectively 
c Rfree was calculated using 5% of all reflections that were excluded at all stages of 
refinement. 
Numbers in parentheses are from the highest resolution shell. 
building was done in O (6).  Three-fold NCS averaging was used throughout initial 
refinement to improve electron density map calculations.  The structure was refined 
using CNS (6). Final refinement statistics can be seen in Table 4.1.   
All figures were made using PyMol (7) and ChemDraw®.  Atomic coordinates 
and structure factors for TmPNP have been deposited into the Protein Data Bank 
(PDB) under the code 1VMK. 
Section 4.3 Results and Discussion  
The structure of TmPNP is very similar to that of bPNP, and has sequence similarity 
of 63% and identity of 44%.  The TmPNP monomer consists of nine β-strands, seven 
α-helices and two 310 helices (Figure 4.1).  The β-strands can be divided up into two 
regions, one that makes a β-sheet and another that makes up a distorted β-barrel.  The 
β-sheet is arranged with the topology β2↓β3↑β4↓β1↓ with helices α1 and α3 on one 
side of the sheet.  The other side is solvent exposed up to the point were the β-sheet 
domain meets with the β-barrel.  The α7 helix contains 27 residues and crosses over at 
this point between strands of the β-sheet and the β-barrel.  The β-barrel contains two 
long strands, β5 and β9, which are 10 and 11 residues, respectively.  Strand β5 forms 
parallel sheet like hydrogen-bonding contacts along β1 for the first five residues, and 
then twists into the β-barrel motif with the final five residues.  The poor electron 
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density between residues 28-30 corresponds to the final turn of α2, which is not 
rendered in Figure 4.1.  The numbering of the helices has been retained, however, to 
maintain the previously established topological convention (2). 
The trimeric structure is characteristic of PNP enzymes seen in eukaryotes, 
although trimeric PNPs have also been seen in bacteria such as Escherichia coli, 
Bacillus subtilis and Bacillus stearothermophilus (2) (Figure 4.2A).  One molecular 
interface between monomers consists of a long loop region spanning residues 132-159 
that interacts with residues 177-188.  An additional loop at this interface spans 
residues 77-88 and contains one 310 helix.  The other significant interface between  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1. Secondary structural elements of the TmPNP monomer with guanine 
modeled into the active site.  Strands are labeled in magenta, helices in blue and 
carbon atoms of guanine in grey. 
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monomers is seen along the three-fold axis surrounded by α5 from each monomer.  
The side of the trimeric structure containing the loop regions has the appearance of a 
bowl with the sides composed of the four-stranded mixed β-sheet and helix α1, and 
the base at the center of the three-fold axis.  The opposite side of the trimer is flat with 
the center composed of the three α5 helices and the base of the β-barrel.   
 Each active site in TmPNP contains the purine guanine which is coordinated 
by exclusively conserved residues.  The catalytic mechanism of PNP is facilitated by 
an asparagine residue, here Asn228, that stabilizes the negative charge that builds on 
the N7 nitrogen during catalysis (1).  The N1 and N2 atoms of guanine are coordinated 
by the conserved residue Glu186.  N9 forms a hydrogen bond with Ala111 and a water 
molecule, while π-stacking interactions with the ring are stabilized by the aromatic 
residue Tyr185 in a T-shaped configuration.  Though Tyr185 is not exclusively  
 
Figure 4.2. A) TmPNP trimer looking down the three-fold axis.  B) Side view of the 
trimer rotated by 90° about the y-axis in figure A illustrating the loop and helix faces. 
 86 
 
conserved, this position is conserved as either tyrosine or phenylalanine in order to 
conserve the π-π stacking interaction.  These residues facilitate the catalytic 
mechanism that generates a free base and ribose 1-phosphate (Scheme 4.1). 
Scheme 4.1. PNP mechanism 
 Comparing thermophilic proteins to their mesophilic counterparts can provide 
insight into the fundamental nature of protein stability and folding in general.  The 
structure of bPNP with both 9-deazahypoxanthine and ribose 1-phosphate bound 
(PDB code: 1A9T) serves as an excellent comparator for TmPNP since both proteins 
are the trimeric form of PNP, were solved to the same resolution, and have a 
structurally similar purine base bound in the active site.   
Some of the key differences that have been implicated in contributing to 
thermostability are the number of proline residues, the presence of intramolecular 
disulfide bridges (8), number of salt bridges, hydrogen bonds, accessible surface area, 
increased polar surface area, hydrophibicity, fewer loop regions and greater 
compactness (3).  Many of these factors are interrelated, and direct comparison of the 
X-ray crystal structures of thermophilic and mesophilic orthologs gives a specific, 
atomic resolution explanation for the differences.  
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TmPNP contains 19 proline residues and 11 salt bridges, while bPNP contains 
13 proline residues and only six salt bridges.  Figure 4.3 depicts the location of each 
proline residue in both bPNP and TmPNP.  Nine of the 13 proline residues in bPNP 
are structurally aligned with those in TmPNP. 
Another variance in residues is that thermophilic proteins tend to have fewer 
cysteine, asparagine and glutamine residues, as these residues tend to undergo 
oxidation and damage the protein at high temperatures (9).  To confirm this, the 
number of cysteine, asparagine and glutamine residues was compared between the 
two.  There is a significantly larger number of each residue in the bovine structure,  
with the number of cysteine, asparagine and glutamine residues at four, 14 and 15, 
respectively compared to TmPNP at two, seven and three, respectively. 
Intermolecular stability also plays a critical role in the formation of the biologically 
active unit.  The interface of each monomeric unit must bind tightly to its neighbor so 
that at high temperatures the quaternary structure is not disrupted.  Table 4.2 contains 
a list of properties generated by the protein-protein interaction server (10) and Spock 
(11), detailing binding interactions which stabilize the multimeric complex in both 
TmPNP and bPNP.  The bovine intramolecular interface harbors more numerous 
binding features such as hydrogen bonds (nine in bPNP compared to seven in 
TmPNP) and significantly more bridging water molecules (11 in bPNP compared to 
four in TmPNP).  The percent of non-polar atoms at this interface, with 67% in 
TmPNP and 60% in bPNP, excludes more water molecules in the TmPNP structure.  
This implies a more tightly packed trimeric structure that excludes water molecules 
from the interface due to the presence of hydrophobic residues.  This is confirmed by 
comparing the van der Waals volume and surface area between bPNP 
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Figure 4.3.: Proline residues in bPNP and TmPNP monomers shown with structurally 
conserved proline residues in blue and non-conserved proline residues in red. 
 
Table 4.2. Intermolecular properties 
Property bPNP TmPNP 
Interface accessible surface area (Å2) 1223 915 
No. of Hydrogen Bonds 9 7 
% Polar Atoms at Interface 40 33 
% Non-Polar Atoms at Interface 60 67 
Bridging Water Molecules 11 4 
Van der Waals Surface Area (Å2) 85813 77530 
Van der Waals Volume (Å3) 60874 53789 
Ratio of S.A to Volume 1.41 1.44 
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Table 4.3. Monomeric properties 
Property bPNP TmPNP %difference1 
No. of proline residues 13 19 37.5 
No. of residues 289 277 4.2 
No. salt bridges 6 11 58.8 
Van der Waals Surface Area (Å2) 28525 23308 20.1 
Van der Waals Volume (Å3) 20183 16828 18.1 
 
1.  
 
and TmPNP (Table 4.3).  TmPNP has a significantly smaller surface area and volume 
compared to bPNP, as shown by the % difference in surface area and volume of 
20.1% and 18.1%, respectively.  The conclusion is that the factors stabilizing the 
trimeric TmPNP structure include having a more compact trimer as a result of the 
greater number of hydrophobic residues at the interface of adjacent monomers 
combined with the lower degree of intramolecular solvation. 
The active site of TmPNP contains a guanine base, so the structurally similar 
9-deazahypoxanthine bPNP structure was used for comparison.  Figure 4.4 illustrates 
the active site of bPNP and TmPNP with their respective ligands bound and hydrogen 
bonding interactions shown.  Residues conserved among PNP enzymes include a 
catalytic asparagine residue and a glutamic acid that stabilizes the N1 and N2 nitrogen 
atoms of guanine.  In both cases there is a short hydrogen bond between the OE1 
oxygen atom of glutamic acid and the N1 atom, with distances of 2.69 Å and 2.81 Å in 
TmPNP and bPNP, respectively.  An aromatic residue is observed above the plane of 
the base, in a T-stacking π-stacking formation.  This residue is Tyr185 in TmPNP and 
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Figure 4.4. Stereoview of the active site residues of A) TmPNP with bound guanine 
(GUN) and B) bPNP with bound 9-deazahypoxanthine (HPA) and ribose 1-phosphate 
(R1P).  Hydrogen bonds are shown as dashed black lines. 
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Phe200 in bPNP, but the aromaticity in this position is confirmed by multiple 
sequence alignment throughout the family of PNP enzymes.   
The bovine structure also contains ribose 1-phosphate bound by several 
conserved residues.  Though the TmPNP structure lacks this phosphorylated sugar, 
overlaying the structures gives information about the geometry of the conserved 
residues required to do so.  Figure 4.4B shows the same structurally aligned residues 
in the TmPNP structure with the exception of His240 which is not located near the 
TmPNP active site.  This corresponds to the most significant structural difference 
between the two proteins, in that α7, the final helix in both structures, diverges with 
the bend in the bPNP structure occurring at the conserved residue Ala267.  This bend 
positions the imadazole ring of His257 in bPNP to make a hydrogen bond with the 
C5′-OH group of ribose 1-phosphate.  Figure 4.5 shows this divergence as well as the 
region corresponding to residues 234-238 in TmPNP that were not ordered in the  
electron density (residues 234-235 are not ordered in chain C).  This bend is also seen 
in bPNP with hypoxanthine bound but lacking ribose 1-phosphate (PDB code: 1A9Q).  
The TmPNP structure lacks ribose 1-phosphate, and the final helix is not bent but 
moved away from the active site.   
Comparing the structures of orthologous proteins from mesophiles and 
thermophiles offers insights into what fundamentally stabilizes intramolecular and 
intermolecular interactions within a protein.  The main feature, observed in the pair 
highlighted in this communication, which stabilizes the oligomeric state of the active 
enzyme is a higher percentage of non-polar residues than polar residues at the  
interface of adjacent monomers.  This results in fewer hydrogen bonding contacts and 
a lower degree of solvation at the interface.  The stability of the oligomeric state of 
proteins at high temperatures appears to have a large contribution from the 
unfavorable entropic effects of breaking the binding interactions seen at the interface 
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and exposing hydrophibic residues to solvent.  An interface with a large percentage of 
polar residues would be more easily solvated, thus leading to more bridging water 
molecules.  Since water molecules are dynamic in nature, as opposed to residues 
which are fixed in place by the topology of the protein, this can weaken the overall 
intramolecular binding interaction in the oligomeric protein as ambient temperatures 
begin to approach the boiling point of water.   
Comparisons between bPNP and TmPNP monomers show what is classically 
believed to be a set of characteristics that differ between mesophilic and thermophilic 
proteins.  TmPNP contains a larger number of proline residues, fewer asparagine, 
glutamine and cysteine residues, and more salt bridges. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Overlaid structure of bPNP and TmPNP illustrating the divergences in the 
final helix, α7.  bPNP is rendered in green, TmPNP in blue, guanine in yellow and 
both 9-deazahypoxanthine and ribose 1-phosphate in red. 
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APPENDIX A 
SUMMARY 
The work presented here encompasses a wide range of interesting biological problems 
through the use of X-ray crystallographic methods.  An atomic resolution structure of 
any enzyme is necessary to fully understand the nature of catalysis.  The binding site 
geometry determines how the substrate not only interacts with the protein to fix it in 
place, but it also the chemistry through the precise positioning of atomic orbitals.  
Reactions that would never take place in solution are readily catalyzed by enzymes 
since their specificity is determined by their individual structure.  As presented here, 
nature has devised a way to solve some complicated biological problems through 
highly creative means. 
 The structure of Thi4 revealed how many organisms overcome their need for 
the essential co-factor thiamin through the biosynthesis of the thiazole moiety.  The 
use of NAD as a substrate allows for the organism to use a readily available metabolite 
that serves many other purposes in the cell.  Interestingly, the hydroxymethyl 
pyrimidine moiety is also made through catalysis by Thi5 with pyridoxal 5´-phosphate 
(PLP) – another essential cofactor (1).  With such a prodigious supply of substrate 
available, this ensures that the organism will be able to generate thiamin whenever it is 
needed.  Structurally, Thi4 exhibits an example of an enzyme that retained a fold that 
was once able to bind the co-factor FAD, but evolved the ability to bind NAD as a 
substrate and no longer require a co-factor.  This change also resulted in the inability 
of Thi4 to bind FAD.  Still, many questions remain as to how Thi4 catalyzes NAD to 
ADT since this involves several catalytic steps.  It has recently been discovered that 
the penultimate intermediate does not spontaneously aromatize into ADT, but rather 
requires a catalytic step to form the five-membered heterocyclic ring of thiazole 
(submitted).  Also, the precise nature of the sulfur transfer step still remains elusive.  
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Originally it was believed that the sulfur atom from the thiazole ring came from a free 
cysteine amino acid.  However, the partially active mutant of Thi4 (C204S) is able to 
generate advanced intermediates, but will not produce ADT if incubated in the 
presence of free cysteine (2).   Also, recent crystallographic and biochemical evidence 
points to the possibility that the sulfur atom comes from an internal cysteine residue 
(Cys205) which is exclusively conserved in all Thi4 orthologs.  The sulfur transfer 
would result in a dehydroalanine residue rendering the enzyme dead.  X-ray electron 
density maps from A. thaliana (3) and N. crassa (unpublished data) Thi4 orthologs 
show no electron density where the γS atom would be located on this catalytic 
cysteine.  A C205S mutant crystal structure of Thi4 from S. cerevisiae shows clear 
density for the γO atom, and is completely inactive (Appendix A Supplemental Figure 
1).  The di-cysteine motif seen in S. cerevisiae is unique to that organism as no other 
known sequence possesses an additional cysteine residue next to the catalytic cysteine 
(Appendix A Supplemental Figure 2).  This leads to the speculation that the sulfur 
 
Appendix A Supplemental Figure 1.  Electron density maps highlighting the 
catalytic cysteine residue in Thi4.  A) Simulated annealing composite omit map from 
A. thaliana (PDB accession code 1RP0).  B) 16-fold averaged SA omit map from the 
Thi4 ortholog in N. crassa. C) Electron density map for the S. cerevisiae C205S 
mutant. 
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transfer step could be followed by the formation of a seven-membered heterocycle 
resulting from a nucleophilic substitution by the thiolate from Cys204 onto the Cβ 
carbon of the newly formed dehydroalanine.  In the case of N. crassa and A. thaliana, 
the hydroxyl group of the adjacent serine residue is far less likely to act as a 
nucleophile, since its pKa is around 16 compared to a pKa of 8.3 for the thiol group on 
cysteine.  
The structure of the CysM-CysO complex provides evidence for the 
mechanistic enzymology of cysteine biosynthesis from a structure based approach.  
Based on the orientation of the active site residues, it is clear that the Lys51, the same 
residue that forms a Schiff base with PLP, acts as the active site base to remove a 
proton from the Cα carbon of the O-acetylserine/PLP adduct.  Previous structural 
studies of the aminoacrylate intermediate (4) and PLP/amino acid adducts (5) also led 
to the speculation that a structure based mechanism whereby the abstraction of the Cα 
carbon is done by the catalytic lysine residue responsible for forming the internal 
aldimine linkage to PLP.  In the case of CysM-CysO, the mechanism does not involve 
sulfide as in the other examples.  The use of a thiocarboxylated ubiquitin like protein 
to carry the sulfur to the α-aminoacrylate intermediate represents a clever example of 
evading the host’s immune system by protecting the sulfur source from oxidation.   
 
 
 
 
Appendix A Supplemental Figure 2.  Sequence alignment from several Thi4 
orthologs highlighting the catalytic cysteine.  The arrow points to Cys204 in S. 
cerevisiae that is not seen in any other ortholog. 
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Furthermore, the CysM-CysO structure is additionally constrained in that the 
less reactive thiocarboxylate must be aligned with the intermediate so that the sulfur 
transfer may take place.  In the afore mentioned examples, sulfide is the sulfur source 
which can easily move through a small channel in the protein to reach the 
intermediate.  Sulfide has far fewer restrictions in movement than a protein like CysO, 
and therefore the CysM-CysO mechanism requires more structural constraints to 
achieve efficient catalysis. 
Another interesting aspect of the CysM-CysO complex can be seen through 
sequence alignments between CysO and CysM orthologs.  Alignments of CysO 
molecules from the Mycobacterium genus show that the residues which contribute to 
protein-protein interactions with CysM are conserved. Conversely, the same alignment 
with CysM orthologs shows that the CysO binding loop is not conserved. This 
unexpected difference implies that CysO, as well as other sulfur carrier proteins with a 
similar biological role, has the ability to bind to a diverse range of protein surfaces and  
Appendix A Supplemental Figure 3.  A) Sequence alignments between CysO 
orthologs.  B) Sequence alignments between CysM orthologs that have a CysO 
binding partner.  Residues involved in CysO-CysM binding are highlighted in boxes 
(black boxes indicate close contacts while blue boxes are involved in hydrogen 
bonding interactions).  
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may even be interchangeable between organisms. 
The structure of PNP from Thermotoga maritima compared to bovine PNP 
is a classic example of key differences seen between thermophilic proteins and their 
mesophilic counterparts.  No single cause has been attributed to the increased stability 
of thermophiles over mesophiles, yet all the characteristics that have been speculated 
to contribute to greater thermostability are seen in the TmPNP comparison with bPNP.  
One reason is that proteins able to withstand high temperatures without denaturing 
have more numerous and stronger intramolecular binding interactions.  Typically 
thermophilic proteins have a greater number of salt bridges, π-cation interactions (6) 
hydrogen bonds and occasionally disulfide bridges (7) than their mesophilic 
counterparts.  Additionally, characteristics attributed to overall structural rigidity are 
more prevalent in thermophiles than mesophiles.  Some of these attributes include a 
greater number of proline residues, and a more compact structure with fewer flexible 
loop regions.  Finally, chemical stability is realized by having fewer cysteine, 
asparagine and glutamine residues which can become oxidized at high temperatures 
(8).   
 Each of the above examples touches on active areas of structural biology 
research.  Thi4 is an important contribution to the understanding of primary 
metabolism.  CysM-CysO provides mechanistic insight into one of the myriad of 
defense mechanisms that Mycobacterium tuberculosis possesses against its host.  
Finally, the structure of TmPNP represents another example of the fundamentals 
behind protein stability.  Together, what has been learned from these three systems 
represents a brief anthology to what the field of structural biology can contribute to 
science.  
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